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Abstract 
Nowadays, there is a great seek of a targeted drug delivery system. Guiding 
magnetic iron oxide nanoparticles to its target with the help of an external magnetic 
field is the principle behind the development of superparamagnetic iron oxide 
nanoparticles (SPIONs) as novelty drug delivery vehicles. The main purpose of this work 
is to develop an improved biodegradable magnetic nanofluid for drug delivery in the 
brain. The drug delivery system allies the superparamagnetic versatility of iron oxide 
nanoparticles with their capacity to increase the therapeutic protein adsorption. 
 The synthesis method that creates the SPIONs – thermal decomposition, was 
studied, and different procedures were tested in order to improve the reaction product 
and to increase the accuracy of the drug delivery targeting. These new procedures 
evaluated the effect of: changing the initial ratio of oleylamine/benzyl ether (A, B and 
C), the time for nanocrystals growth (A*, B* and C*), the addition of seeds in the 
synthesis process (A+A, B+B and C+C) and the amount of the precursor (A(2x) and C(2x)) 
used on the characteristics of the obtained nanoparticles. The stability of the SPIONs 
suspensions and their capacity to adsorb proteins (BSA and α-casein) were also tested, 
as well as the cytotoxicity of the produced SPIONs. 
Procedure C(2x) revealed itself the most promising to synthesize high quality, size 
controlled SPIONS. As desired, DLS, XRD and TEM tests showed an increase of particle 
sizes (~10 nm) for the samples prepared by this procedure. Although XRD and 
Mössbauer analysis indicate a mixture between magnetite and maghemite in the 
particles, the content of magnetite was also increased. VSM results also showed 
improved magnetization saturation (68 emu/g at 300 K and 78 emu/g at 2 K) with the 
SPIONs obtained from procedure C(2x). The protein adsorption tests on these SPIONs 
proved that the adsorption can be enhanced when the dependence relation between 
the dispersive solution and the protein to be adsorbed was considered. 
The obtained results on the characterization performed on the various samples 
seem promising towards a biodegradable magnetic iron oxide nanofluid for drug 
delivery in the brain. However, further studies are required in order to improve this drug 
delivery system and to evaluate the drug releasing kinetics. 
Keywords: SPIONs; drug delivery; superparamagnetism; protein adsorption; 
biodegradable magnetic nanofluid, TEM, XRD, Mössbauer spectroscopy. 
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Resumo 
Os sistemas de libertação localizada de fármaco são uma necessidade atual. A 
condução de nanopartículas de óxido de ferro até ao seu alvo através de um campo 
magnético aplicado é o princípio do desenvolvimento de nanopartículas 
superparamagnéticas de óxido de ferro (SPIONs) como novos veículos de libertação de 
fármaco. O principal objetivo deste trabalho foi desenvolver um nanofluido magnético 
biodegradável para libertação de fármacos no cérebro. Um sistema de libertação de 
fármaco alia a versatilidade associada ao superparamagnetismo das nanopartículas de 
óxido de ferro, com a sua capacidade de aumentar a adsorção de proteínas terapêuticas.  
O método de síntese – decomposição térmica, que cria estes SPIONs foi estudado 
e, diferentes procedimentos a partir deste método foram testados, de modo a melhorar 
o produto da reação e a aumentar a eficácia do sistema de libertação localizada de 
fármaco. Estes novos procedimentos avaliaram o efeito: da alteração do rácio inicial de 
oleilamina/éter benzílico (A, B e C), do tempo de crescimento dos nanocristais (A*, B* e 
C*), da adição de sementes no processo de síntese (A+A, B+B e C+C) e da quantidade de 
precursor (A(2x) e C(2x)) usado; nas características das nanopartículas obtidas. A 
estabilidade das suspensões de SPIONs e a sua capacidade de adsorver proteínas (BSA e 
α-caseína) foi também testado, assim como a citoxicidade dos SPIONs produzidos. 
O procedimento C(2x) revelou-se o mais promissor na síntese de SPIONs de alta-
qualidade e de tamanho controlado. Como era desejado, os testes de DLS, XRD e TEM 
exibiram um aumento nos tamanhos das partículas (~10 nm) para amostras obtidas por 
este procedimento. Apesar das análises recorrendo a espectroscopia de Mössbauer e 
XRD indicarem uma mistura de magnetite e maghemite, o conteúdo de magnetite foi 
também aumentado. Os resultados obtidos por VSM mostraram uma saturação de 
magnetização melhorada (68 emu/g a 300 K e 78 emu/g a 2 K) com os SPIONs obtidos 
pelo procedimento C(2x). Os testes de adsorção proteica nos SPIONs provaram que esta 
pode ser aprimorada, quando a relação de dependência entre a solução dispersiva e a 
proteína a ser adsorvida foi considerada. 
Os resultados obtidos na caracterização das várias amostras, parecem 
promissores na obtenção de um nanofluido magnético biodegradável de óxido de ferro 
para libertação de fármaco no cérebro. Contudo, estudos adicionais são ainda 
necessários de modo a melhorar o sistema de libertação de fármaco e avaliar a cinética 
de libertação do mesmo.  
Palavras-chave: SPIONs; libertação de fármaco; superparamagnetismo; adsorção 
proteica; nanofluido magnético biodegradável, TEM, XRD, espectroscopia de 
Mössbauer. 
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1. Introduction 
The actual knowledge and the ability to control the matter at its most fundamental 
level (atomic and molecular scales), learned by nanoscale science and engineering, 
allowed the development of systems that have great interest to biomedical applications. 
In particular, nanoparticles have attracted great attention due to their particular 
electronic [1], optical [2] and magnetic [3] properties.  The nanodimension of these 
particles enables their use for nanoengineering of surfaces and the production of 
functional nanostructures. These modifications make easier their application in the 
biomedical area, for instance, for targeted drug delivery in delicate, damaged and not 
well-known organs, like the brain.  
The main problems usually associated with drug administration include the 
general systemic distribution of therapeutic drugs, the necessity of a large dose to 
properly achieve the desired site, the lack of drug specificity towards a pathological site, 
nonspecific toxicity, and other adverse side effects. The use of superparamagnetic iron 
oxide nanoparticles (SPIONs) is one of the main solutions to overcome the mentioned 
problems of drug delivery involving magnetic targeting. Their inherent 
superparamagnetism provides them the ability of being targeted to the required area 
through an external magnetic field application, as they behave like a giant paramagnetic 
atom granting a quick response to the applied magnetic fields with negligible remnant 
magnetization momentum and coercivity. This is a fundamental aspect in biomedical 
applications since it decreases the risk of forming agglomerates [4]. Due to such 
properties, the particles do not show magnetic interaction after the removal of the 
external magnetic field. The concept of using magnetic carriers coupled with an external 
magnetic field was firstly introduced in the late 1970s  by Freeman et al. [5]; nowadays, 
a variety of magnetic nanoparticle carriers have been developed and optimized to 
deliver drugs to target sites in vivo [6– 8]. The optimization of these carriers has two main 
goals: to reduce both the amount of accumulated systemic distribution of the cytotoxic 
drug and the dosage required by more efficient, localised targeting of the drug.  
Magnetic targeting is related with a magnetic force applied on SPIONs by a 
magnetic field gradient. The therapy efficiency depends on some significant parameters 
such as: the mentioned field gradient, the field strength and the volumetric and 
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magnetic properties of the particles. The magnetic field gradient is generated by a strong 
permanent magnet fixed outside the body over the target site. The drug-carrier 
complexes, usually a biocompatible nanofluid, are normally injected into the patient via 
the circulatory system. Once the drug-carrier complexes are concentrated at the target, 
the drug is released either via enzymatic activity or changes in environment 
physiological conditions such as pH, osmolality, or temperature [6], and may be 
internalized by the cells of the target tissue [9].  
SPIONs application in medical therapy associated to pathologies in the brain 
requires their stabilization in water at neutral pH and physiological salinity. Such 
dispersion stability depends on the dimensions of the particles, which should be 
sufficiently small to avoid precipitation due to gravity forces.  
Nanoparticles size affects their ability to extravasate from the vasculature. While 
most endothelial barriers allow nanoparticles <150 nm in diameter to pass, more 
stringent barriers, such as the blood-brain barrier (BBB) are far more restrictive. The BBB 
allows passive diffusion of only small, neutrally charged lipid soluble molecules, 
prohibiting >98% of all potential neurotherapeutics from passing through it. 
Consequently, this has become an area of intense research in the development of 
treatment strategies for brain tumors, Parkinson’s, Alzheimer’s, and Huntington’s 
diseases. To determine the influence of nanoparticles size on BBB permeability, 
Sonavane et al. recently reported that gold nanoparticles of 20 to 50 nm in 
hydrodynamic size could permeate across the BBB, while larger nanoparticles, 
specifically 100 and 200 nm sized could not. However, BBB permeability is likely 
influenced by all physicochemical properties of the drug delivery system and 
nanoparticles size alone may not dictate their permeability across the BBB [10].  
Another important factor is the charge and surface chemistry, which gives rise to 
both steric and coulombic repulsions [11]. Because of their oxidative instability, SPIONs 
must have a protective shell against degradation. This shell is also used to bind specific 
drugs, proteins, enzymes, antibodies and other molecular targets [12]. 
Other important criteria to take into account for their biomedical applications is 
the cytotoxicity of SPIONs. The nature of the magnetically responsive component and 
the final size of the particles, including their core and the coatings, are some aspects 
that determine their cytotoxicity [13]. 
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Also, targeting SPIONs into specific cells is an important issue. It is severely limited 
by a short blood half-life of the particles, non-specific targeting, and low internalization 
efficiency of surface grafted ligands [13]. Various efforts are directed towards improving 
these properties of SPIONs and modifying their synthesis methods to better control their 
size and surface.  
During the development of this thesis, drug delivery using SPIONs as carriers will 
be studied, but their use in other applications is also important: their use in high 
resolution molecular imaging and in cancer treatments by hyperthermia has also been 
in development and shows promising results [12][14].  
1.1. Objectives and motivation 
During the development of this thesis we intended to study into further detail the 
synthesis of superparamagnetic iron oxide nanoparticles obtained by thermal 
decomposition of iron acetylacetonates. To have an accurate knowledge of the process 
involved in this synthesis, several aspects that could affect the reaction were addressed, 
such as the use of different amounts of the iron precursor, nucleation and growth times, 
as well as various ratios between solvent and surfactant.  
Besides studying the effect of some synthesis parameters on the iron oxide 
nanoparticles characteristics, the observation of the effects of coating the nanoparticles 
with some surfactants and posterior protein loading on their properties were also 
investigated. The proteins that were more efficiently adsorbed on the obtained 
nanoparticles in an administration environment were also selected. 
Mössbauer spectroscopy and XRD analysis were the main techniques used to 
determine the formed iron oxide phases. TEM and DLS were applied to accurately 
determine the nanoparticles size. FTIR allowed to confirm the presence of the chemical 
groups on the protective shell of the nanoparticles. VSM allowed us to quantify the 
magnetic properties of the prepared nanoparticles. The Zeta Potential was also applied 
to determine the surface charge of the nanoparticles in different pH solutions with the 
aim of better selecting the more interesting therapeutic protein loaded on the 
nanoparticles and determining the efficiency of its adsorption. The samples were also 
subjected to cytotoxic analysis to confirm their biocompatibility. 
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As motivation, it is expected that this work will contribute to a better 
understanding of the studied nanoparticles synthesis method and properties, and assess 
the effects and changes in their properties when they are treated with different 
surfactants and/or loaded with different therapeutic proteins. We believe that this will 
help the further development of the application of a biodegradable nanofluid as a vector 
for drug release in the human brain.  
1.2. Thesis outline 
This thesis was organized in six chapters. In the present chapter, chapter 1, the 
framework objectives and motivation for this work and a brief summary of contents are 
presented. 
In chapter 2, the basic theoretical concepts related to magnetism and the type of 
magnetization phenomena exhibit by the nanoparticles with interest for this work are 
explained. Furthermore, some information related to SPIONs as drug delivery carriers 
and their synthesis methods will be described, as well as the basic principles needed to 
understand the characterization techniques applied in this work. 
Chapter 3 will focus on enlightening the used experimental methodology. A 
detailed description of the experimental assembly and the steps of the original synthesis 
method (based on literature) and its modifications, which were developed during the 
course of this work; will be done throughout this chapter. Chapter 3 also contains the 
methodologies for characterizing the samples with the different analytical techniques. 
All the chosen routes will be explained and the obtained results will be discussed 
in chapters 4 and 5. Chapter 4 will mainly focus on the physical analysis of the samples 
such as nanoparticles size, their oxide phase, magnetic properties, and chemical groups 
of their protective shell. Chapter 5 discusses the influence of surfactant coating in 
SPIONs stability of water dispersions, the SPIONs cytotoxic results, and the protein 
adsorption quantification. 
In the last chapter, chapter 6, the final conclusions will be presented and 
suggestions for future works will be formulated. 
  
5 
 
2. Basics Theoretical Concepts 
The basic theoretical concepts covering all the themes related with magnetism 
and types of magnetization phenomena, particularly important for the synthesized 
nanoparticles, are described in this section. The knowledge about the physical 
characteristics of iron oxide nanoparticles and the drug delivery application focused on 
brain treatment is also gathered. Moreover, all basic principles associated with the 
characterization techniques used throughout the course of this work are also covered in 
this section. 
2.1. Magnetism 
Magnetism was first approached in ancient Greece (VI century BC) in a region 
called Magnesia, where the Greek philosopher Tales de Milo observed a strange 
behaviour of a certain stone.  Those so called lodestones exhibited the property to 
interact with each other (attracting or repelling themselves) or attract materials such as 
iron. Simultaneous Greek and Chinese studies involving this naturally magnetized form 
of the mineral magnetite, and all the phenomena related to it, introduced the concept 
of magnetism; that knowledge led to the first application of a magnetism related 
invention, the magnetic compass [15]. 
Despite that antique empirical knowledge, theoretical magnetic phenomena were 
only systematically studied after the XVII century, when in 1600 William Gilbert, author 
of De Magnete, Magneticisque Corporibus, et de Magno Magnete Tellure, enunciated 
the fundamental properties of magnetism and discovered the Earth’s magnetic field. In 
the XVII century, Charles-Augustin de Coulomb developed Magnetostatic laws, similar 
to the ones that governed the attraction and repulsion movements between electric 
quiescent charges. He postulated that a magnetic force between objects was directly 
proportional to some quantities that he called magnetization units, or magnetic pole 
intensities, and inversely proportional to the square of the distance between the 
objects.     
Nowadays, there are multiple interesting studied effects involving magnetism in 
condensed matter systems, knowing that the atoms in these systems have magnetic 
moments and that these moments, somehow, interact with each other. In real systems 
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there is a wide diversity of magnetic properties that can exist, and that can be explained 
by the variety of magnetic interactions, which are dependent on whether or not the 
magnetic moments can act together in a cooperative way [15]. 
2.1.1. Diamagnetic, paramagnetic and ferromagnetic materials 
There is always a duality in materials due to their magnetic susceptibility and, 
concerning it, materials may be classified by their behaviour to externally applied 
magnetic fields as diamagnetic, paramagnetic, or ferromagnetic. That duality is 
explained by the opposition (diamagnetic material) or alignment (paramagnetic 
material) of the induced magnetic momentum with the applied magnetic field which 
caused it [15]. 
Since diamagnetism is an inherent property of all materials, there is a balance 
between diamagnetic and paramagnetic effects and, depending on which effect 
overcomes the other, those materials are classified as diamagnetic or paramagnetic. 
When there is no applied magnetic field to a paramagnetic material, its magnetic 
momentum points in random directions because there are weak interactions between 
neighbouring atoms. The magnetization of a paramagnetic material directly depends on 
the intensity of the applied magnetic field, and inversely depends on the temperature 
of the material as shown by the Curie’s law: 
     𝑀 = 𝐶 ×
𝐵
𝑇
   ,                                                             (1) 
where M is the magnetization, B is the magnetic field, C is the constant of Curie and T is 
the temperature of the material, in Kelvin. Consequently, an increase of the applied 
magnetic field will align the spins whereas an increase of temperature will randomize 
them [15]. 
Ferromagnetic materials exhibit a long-range ordering phenomenon at the atomic 
level, which causes the unpaired electron spins to line up parallel with each other in a 
region called a domain. Within the domain, the magnetic field is intense, but in a bulk 
sample the material will usually be unmagnetized because the many domains will 
themselves be randomly oriented with respect to one another. Ferromagnetism 
manifests itself in the fact that a small externally imposed magnetic field can cause the 
magnetic domains to align with each other and the material is said to be magnetized. 
The driving magnetic field will then be increased by a large factor which is usually 
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expressed as a relative permeability for the material. These materials will tend to stay 
magnetized to some extent after being subjected to an external magnetic field. This 
tendency to "remember their magnetic history" is called hysteresis [15]. 
A commonly used magnetic quantification that differentiates these type of 
materials is their bulk magnetic susceptibility, which specifies how much the relative 
permeability differs from one. The bulk magnetic susceptibility is expressed by:   
                       χm = km – 1,                                                               (2) 
where km is the relative permeability. For paramagnetic and diamagnetic materials the 
relative permeability is very close to 1 and the magnetic susceptibility very close to zero 
(≈-10-5 and ≈10-5-10-3, respectively). For ferromagnetic materials, this quantity may be 
very large (≈50-104) and they will undergo a small mechanical change when magnetic 
fields are applied, either expanding or contracting slightly [16]. 
2.1.2. Ferrimagnetic materials 
Ferrimagnetism is a type of permanent magnetism that occurs in solids in which 
the magnetic fields associated with individual atoms spontaneously align themselves, 
some parallel, or in the same direction (as in ferromagnetism), and others generally 
antiparallel, or paired off in opposite directions (as in antiferromagnetism). 
Ferrimagnetism occurs mainly in magnetic oxides known as ferrites. The natural 
magnetism exhibited by lodestones, recorded as early as the 6th century AC, is that of a 
ferrite, the mineral magnetite, a compound containing negative oxygen ions O2- and 
positive iron ions in two states, iron(II) ions, Fe2+, and iron(III) ions, Fe3+. The magnetic 
behaviour of the two sublattices that make the crystallographic arrangement is the 
explanation for this magnetic phenomenon. When the magnetization of the sublattices 
is not equal and opposite, then they cannot cancel each other, resulting in a net 
magnetization of the material. Due to the different molecular field in each sublattice, 
they have a distinguish temperature dependence, which means that one of the 
sublattices can dominate the magnetization at a higher temperature while the other 
dominates at a lower one. When this occurs, the net magnetization will be decreased to 
zero and changes sign at a temperature identified as the compensation temperature [15]. 
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2.1.3. Superparamagnetic materials 
Superparamagnetism is a phenomenon related to the decrease in size of materials 
and leads to delicate and ultimately valuable modifications in their magnetic behaviour. 
When the particle size is reduced below a specific critical size, the material changes its 
behaviour from a multi-domain system to a single-domain one. This behaviour 
modification occurs if the cost of domain wall formation is not compensated by savings 
in demagnetizing energy, causing a single-domain particle constrained to lie parallel or 
anti-parallel to the direction of the applied magnetic field [15]. 
Assuming that each particle in a non-magnetic matrix is sufficiently far apart so 
that no interparticle interaction exists, then this system will behave similar to a 
paramagnetic one differing in each independent moment; there is then a large group of 
moments instead of longer atomic one, as was before. Each of those large groups is 
inside each and every particle of the system and that is what is known as a 
superparamagnetic system [15]. 
When working with nanoparticles, a uniaxial magnetic anisotropy is considered 
where the magnetic anisotropy energy is expressed by: 
                                                     𝐸(𝜃) = 𝑘𝑉 (sin 𝜃)2,                                                   (3) 
being k the magnetic anisotropy constant, V the particle volume and 𝜃 is the angle 
between the magnetization direction and the easy direction of magnetization. The 
previous equation shows that the magnetic anisotropy energy has two minima at 𝜃=0o 
and 𝜃=180o, separated by an energy barrier kV. The phenomenon called 
superparamagnetic relaxation can be described as the spontaneous fluctuations of 
magnetic nanoparticle’s magnetization direction between the easy directions 
corresponding to the two minima, which are a consequence of an energy barrier smaller 
than or comparable to the thermal energy. 
2.2. Iron oxides 
Iron oxides are common compounds which are abundant in nature and readily 
synthesized in laboratory. They are present in all of the different compartments of the 
global system: atmosphere, pedosphere, biosphere, hydrosphere and lithosphere. The 
logical consequence of this widespread distribution of iron oxides is that many different 
scientific disciplines (such as Biology, Geology, Industrial Chemistry, Medicine, etc.) have 
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an interest in them. Naturally this has led to a much fruitful, interdisciplinary 
communication and interaction [17]. 
There are sixteen iron oxide/hydroxide compounds distributed in oxides, 
hydroxides or oxyhydroxides. The iron oxides are composed of Fe together with O 
and/or OH but only six out of those sixteen have only iron and oxygen. Throughout the 
course of this work only two of those six will be more deeply discussed: magnetite and 
maghemite. To allow the distinction between these interchangeable iron oxides, some 
physicochemical properties are described and exhibited in Table 1 [17]. 
 
Table 1. Physicochemical properties of Magnetite (Fe3O4) and Maghemite (ɣ-Fe2O3) 
  
2.2.1. Magnetite 
Magnetite or lodestone, Fe3O4, is a black, ferromagnetic mineral containing both 
FeII and FeIII. Together with titanomagnetite, it is responsible for the magnetic properties 
of rocks, which are objects of paleomagnetic studies. It has an inverse spinel structure 
as shown in Figure 1 but, below Verwey transition temperature (Tv = 120 K), the species 
of Fe2+ and Fe3+ arrange themselves in a regular pattern, turning into a normal spinel 
structure [17]. 
 
 
 
 
 
 
 
 
Iron Oxide Formula 
Crystallographic 
structure 
Lattice 
parameter 
– a (nm) 
ρ 
(g.cm-
3) 
Curie 
Temperature 
(K) 
Magnetization 
saturation at 
300K (emu/g) 
Magnetite 
(Black) 
Fe3O4 Cubic 0.8396  5.18 850 92 - 100 
Maghemite 
(Reddish-
Brown) 
γ-Fe2O3 
Cubic or 
tetragonal 
0.8347  4.87 820 - 986 60 - 80 
Fe2+/Fe3+ at B sites 
O2- 
Fe3+ at A sites 
Figure 1. Crystallographic structure of magnetite (inverse spinel). 
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In order to determine the details of its structure, magnetite was one of the first 
mineral structure to which X-ray diffraction was applied by Bragg in 1915. It is defined 
as having a face-centred cubic unit cell on an inverse spinel structure with a unit cell 
edge length of 0.8396 nm.  
Due to divalent (Fe2+) and trivalent (Fe3+) iron atoms present in magnetite, the two 
main crystal sites are occupied in different ways. While tetrahedral sites or A sites are 
occupied with Fe3+, the octahedral ones or B sites are distributed between Fe2+ and Fe3+. 
The good electrical conductivity presented by this iron oxide is explained by the 
crystallographic spatial changes of Fe2+ and Fe3+ ions, along the close packed structure. 
Those cation substitutions are accompanied by changes in the unit cell edge length.  
Since magnetite can be slightly metal deficient on Fe3+ octahedral sites, causing 
vacancies, its stoichiometric Fe2+/Fe3+ ratio of 0.5 is often not attained [17]. 
Two interpenetrating magnetic sublattices with antiparallel spins are formed by 
the two cation sites in the structure - A and B sites, in which the spin direction is equal 
but its magnetic extents are not. In condensed macro systems, at room temperature, 
this results in a ferrimagnetic effect that is modified into a superparamagnetic behaviour 
when magnetite particles have a size below a constant critical and nanometric size: 25-
30 nm [17]. 
At atmospheric O2 pressure, magnetite is thermodynamically unstable due to its 
mixed valence. That fact makes magnetite much more susceptible to oxidation which is 
related with an incessant decrease of Fe2+ levels in its composition and a consequent 
cell edge change, although the crystal size and morphology remain constant [18]. 
2.2.2. Maghemite 
Maghemite (γ-Fe2O3) is a reddish-brown ferrimagnetic iron oxide and is the second 
most stable polymorph of iron oxide. It occurs naturally in soils as a weathering product 
of magnetite (Fe3O4), to which it is structurally related [17].  
Both maghemite and magnetite exhibit a spinel crystal structure, but while the 
latter contains both Fe2+ and Fe3+ cations in octahedral sites, in maghemite all the iron 
cations are in trivalent state, and the charge neutrality of the cell is guaranteed by the 
presence of cation vacancies in those sites, where in magnetite a divalent iron state 
atom exists. Maghemite can have different symmetries depending on the degree of 
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ordering of those vacancies and its structure can be obtained by creating 8/3 vacancies 
out of the 24 Fe sites in the cubic unit cell of magnetite. That’s the reason why 
maghemite has a cubic unit cell value of 0.83474 nm, which is slightly below the unit cell 
value for magnetite [18].  
The presence of vacant sites in maghemite makes its magnetic structure 
composed by one sublattice in tetrahedral sites and another in the octahedral sites. The 
spin sublattices orientations are both antiparallel with a difference of magnitude 
between each other, resulting in ferromagnetic behaviour at room temperature. When 
maghemite particles have a size below 10 nm, the magnetic system behaves 
superparamagnetically [17]. 
2.3. Synthesis of magnetic nanoparticles 
Two types of methods are described in the literature for synthesis of magnetic 
nanoparticles, physical and chemical ones. Physical methods such as gas-phase 
deposition and electron beam lithography are elaborated procedures incapable of 
controlling particle size in nanometric scale. Unlike these physical procedures, the 
chemical ones are known to produce highly stable, high-quality, monodispersive and 
shape and size-controlled nanoparticles [19]. In fact, in 2011, Mahmoudi et al. proved 
that 90% of magnetic nanoparticles are synthesized using chemical procedures [20]. The 
following table presents and compares the chemical procedures more often used in the 
synthesis of magnetic nanoparticles. 
Table 2. Comparison between different chemical methods for synthesis of magnetic nanoparticles [4]. 
Method 
Thermal 
decomposition 
Hydrothermal 
synthesis 
Co-precipitation Microemulsion 
Synthesis 
Complex, inert 
atmosphere 
Simple, high 
pressure 
Very simple, 
ambient 
conditions 
Complex, inert 
atmosphere 
Reaction 
temp. (oC) 
100 - 320 220 20 – 90 20 - 50 
Reaction 
period 
Hours-days Hours-days Minutes Hours 
Solvent Organic Water-ethanol Water Organic 
Size 
distribution 
Very narrow Very narrow Narrow Narrow 
Shape 
Control 
Very good Very good Poor Very Good 
Yield High scalable Medium High scalable Low 
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Although thermal decomposition involves complex processes and requires higher 
temperatures and a longer reaction period, a very narrow size distribution can be 
obtained, a very good shape control of nanoparticles, and a high and scalable yield can 
be achieved (see Table 2). Those aspects fit perfectly on the requirements of our work. 
As result of that, thermal decomposition was the nanoparticle synthesis route used 
throughout the course of this work, and the principle basics involved in this type of 
synthesis will be next described.     
2.3.1. Thermal decomposition 
Thermal decomposition is a very promising synthesis method that allows obtaining 
of mono-dispersive and high-quality magnetic nanoparticles, which is highly desirable 
when trying to control their physicochemical properties [21]. 
There are several important aspects in this synthesis method that influence the 
control of the size and morphology of the obtained magnetic nanoparticles such as the 
ratio between reagents, the reaction temperature and time, as well as the posterior 
aging period [4]. 
This method involves the thermal decomposition of organometallic compounds in 
high-temperature boiling solvents containing stabilizing surfactants. The most often 
used organometallic precursors are acetylacetonates, being oleylamine, oleic acid and 
fatty acids the most conventional surfactants [4]. Nanoparticles formed by this method 
follow a sol formation mechanism known as nucleation process, where the initial 
number of particles and its subsequent growth is crucial [22]. 
From the formation of the new solid phase energy is released, which is 
thermodynamically balanced with the energy needed to form the surface of small nuclei 
in this same phase. Therefore, the surface free energies are responsible for the growth 
of colloidal particles. Exchange of molecules amongst the particles will happen so that 
equilibrium with the solution surrounding them can be achieved. Above a critical size, 
clusters tend to grow and if the dispersion contains particles with multiple sizes, a 
diffusional flow of solutes will occur from the smaller particles to the largest [22].  
Nucleation and growth processes from a supersaturated system can be described 
using a model implemented by La Mer. When the reaction begins, the dissolved solute 
increases at a stabilized rate, until the critical supersaturation point of concentration is 
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achieved. At this stage, nucleation starts to occur. Eventually, nucleation will cause a 
decrease in concentration; at that point particle growth is substituted by particle 
nucleation and the concentration will continue to decline, due to growth mediated by 
diffusion, until it reaches an equilibrium solubility value [22]. 
It is important to clarify that if more nuclei are formed at the beginning of the 
process, the obtained nanoparticles will be smaller because the same amount of mass 
is going to be distributed by more nucleation centres [22]. 
 
 
 
 
 
 
 
 
 
 
Figure 2 exemplifies the different stages previously explained when applied to the 
specific reaction synthesis to be used in this work. The nucleation process is guaranteed 
when an 110oC threshold is established and the subsequent growth of nanocrystallites 
is obtained at a higher threshold of 300oC. When this threshold is obtained, a 
nanostructured iron oxide composed by magnetite/maghemite nanoparticles starts to 
form through the aggregation of the nucleation cores. 
Figure 2. Different phases of the reaction - details for the system under study. 
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2.4. SPIONs in drug delivery systems 
Most of SPIONs applied in drug delivery consist of nanoparticles, nanospheres, 
liposomes and microspheres. In these systems, the drugs are bound to the surface of 
SPIONs (especially for nanoparticles) or encapsulated in magnetic liposomes and 
microspheres. The recent applications of SPIONs in diagnosis and therapy are presented 
in Figure 3.  
 
In order to minimise the side effects and the required dosage of the drugs, the 
surface engineered SPIONs (e.g. with targeting ligand/molecules attached to their 
surfaces) are used together with an external magnetic field so that the particles can be 
taken to the proper drug release site [23]. 
With the aim of obtaining the desired drug delivery system, with uniform 
biophysicochemical properties, a very narrow size distribution of the SPIONs coupled 
with superparamagnetic properties should be considered. 
The magnetic properties are strongly associated to impurity content, structural 
imperfections of the particles or the composition of their protective shell. The 
concentration of SPIONs in solutions is also a crucial factor affecting magnetic 
properties. When the concentration of magnetic nanoparticles is increased, a clustering 
of the particles may occur, leading to magnetic interactions and to a subsequent 
significant effect on the net magnetization. 
Figure 3. Diagnostic and therapeutic applications of SPIONs. 
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In addition to the superparamagnetic properties that SPIONs must exhibit, careful 
consideration should also be given to SPIONs with different sizes and shapes, due to 
their different behaviour along distinct fluid environments. During the movement 
through the systemic circulation, the SPIONs will suffer the effect of a viscous force 
rather than an inertial force [24].  
The stabilisation of SPIONs in a biological suspension is a critical matter in order to 
improve their function as drug carriers. The changes in the isoelectric point of SPIONs 
(due to the type of coating used), their size distribution, shape, surface characteristics, 
concentration and volume, as well as reversibility and strength of the drug-nanofluid 
bond, access to the organism, rate of the injection, duration of magnetic field application 
and geometry and strength of the magnetic field, are crucial parameters that affect the 
colloidal stability of drug-loaded SPIONs [25].  
2.4.1. Limitations of SPIONs for drug delivery 
- Restriction and progress in magnets  
The major limitation of SPIONs for drug delivery applications is the inadequate 
magnetic gradient (due to the distance between magnet and targeted site) in order to 
control the residence time of nanoparticles at the targeted site. Preliminary 
investigations of the hydrodynamics of drug targeting suggest that for most magnetite-
based carriers, flux densities at the target site must be of the order of 0.2 T with field 
gradients of approximately 8 T m−1 for femoral arteries and greater than 100 T m−1 for 
carotid arteries [26]. This suggests that targeting is likely to be most effective in regions 
of slower blood flow, particularly if the target site is closer to the magnet source. Two-
dimensional computational simulations of magnetic particle motion in the carotid artery 
have been performed [27]. They showed that it was not possible to obtain a maximum 
magnetic force on a magnetic particle inside the body using an externally applied 
magnetic field. Since drug targeting is affected by pulling magnetic particles to the edge 
of blood vessels, this suggests that it will not be possible to target interior regions of the 
body without strongly targeting some of the surrounding regions. Thus, the use of 
magnetically targeted drug delivery carriers with an externally applied field is 
appropriate only for targets close to the surface of the body. 
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- Brain delivery 
Results have confirmed the low efficiency of SPIONs for brain targeted imaging 
and drug delivery applications, due to their restrictions in crossing the blood-brain 
barrier (BBB) [28]. The BBB, which has the role of isolate the brain tissue with special 
endothelial cells, has the potential to inhibit the entrance of therapeutic compounds 
(e.g. for treatment of neurological or psychiatric disorders) to the brain [29]. One 
alternative is the direct injection of SPIONs to the desired part of the brain tissue by 
disruption of the BBB; however, this method may cause unpredictable and high risks for 
patients. In one study, SPIONs with a size of 10–20 nm were taken up by the blood 
tumour barrier and their ability to target rat glioma tumours was analysed [30]. It is worth 
noting that a magnetic field of 0.6 T was applied to the brain in order to increase the 
targeting efficiency. After specific times, the rats were sacrificed and the brain tissue 
was analysed for iron contents. The results confirmed significant differences between 
the SPIONs-targeted tumour tissues and normal ones (i.e. a 2–21 fold increase in 
concentration for 0.5 and 6h after injection of SPIONs, respectively) with a low  total 
concentration of SPIONs in normal brain tissue. 
2.5. Nanoparticles characterization techniques 
2.5.1. X-Ray Diffraction (XRD) 
XRD has a good potential for the analysis of nanoparticles, due to yield information 
about the substructure of the materials (sizes of crystallites, microstrain of a lattice, 
dislocation structures, etc.). Since it is based on the long range order of the atoms, X-ray 
diffraction is also one of the most reliable characterization techniques used to identify 
iron oxides crystalline phases.  
The operating basis is related to electromagnetic radiation (X-ray) interacting with 
the atoms of the sample to be analysed. Depending on how the X-ray beam interacts 
with the crystal planes of the solid, the crystal lattice composed by those atoms diffracts 
X-ray in various directions, which results in distinct diffraction patterns or diffractograms 
[31]. These diffraction patterns work as a very specific crystallographic print that should 
be compared and matched with reference ones from existing databases [17]. 
Depending on the X-ray source and positioning of the electromagnetic beam, the 
X-ray that interacts with the sample has its characteristic wavelength (λ) and hits the 
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sample with an oriented angle of incidence (𝜃). When an X-ray beam hits an atom, the 
electrons around the atom start to oscillate with the same frequency as the incoming 
beam. In almost all directions, destructive interference will take place, as result of the 
combining waves being out of phase, and there is no resultant energy leaving the solid 
sample. However, the atoms in a crystal are arranged in a regular pattern and, in a very 
few values of 𝜃, constructive interference will occur with the defined sets of parallel 
planes of the crystal, with interplanar spacing (d) enhancing the intensity of the 
diffracted radiation. Bragg’s equation correlates all these parameters: 
𝑛𝜆 = 2𝑑ℎ𝑘𝑙 sin 𝜃                                          (4) 
where n is an integer indicating the order of diffraction and dhkl is the lattice spacing of 
the plane family (hkl) of the sample [31]. Since each crystalline phase has its characteristic 
set of interplanar spacing and intensities, it’s possible to identify the phase of the sample 
under study [17].  The ultimate condition for Bragg’s law application is that the incident 
beam and the diffracted beam should be symmetric in relation to the normal of the 
diffracting surface, as shown in Figure 4. 
 
The intensities of the obtained diffracted radiation for 2𝜃 angles appear in 
diffractograms as diffraction peaks and they are related to the diffraction of the incident 
beam by a set of crystal planes with the same interplanar spacing, each one identified 
by their own Miller indices hkl. Each peak is characterized by 3 significant features: 
position, intensity and shape [31].  
Figure 4. Schematic representation of X-ray diffraction phenomenon (Bragg’s Law). 
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In a brief description, the position is related to the medium value of dhkl, depending 
on the unit cell parameters, while the integrated intensity is proportional to the number 
of crystallites in the cited conditions for Bragg’s diffraction, and influenced by the 
orientation of coherent domains of diffraction. On the other hand, the shape of the 
diffraction peaks is related to the dimension and deformation of each coherent domain. 
The Full Width at Half Maximum (FWHM) of a diffraction peak is another 
parameter to consider and results from a convolution of three distinct effects: the size 
of crystallites, the instrumental resolution and the degree of strain. The average size of 
crystallites (D) is determined using the Scherrer formula: 
𝛽 =
𝜀𝜆
𝐷 cos 𝜃
   ,                                                                       (5) 
where β is the FWHM of the peak in terms of 2𝜃 and measured in radians, ε is a form 
factor of the crystallites, usually with an approximated value of 0.9 and λ is the 
wavelength of the incident X-ray beam. The FWHM due to instrumental resolution can 
be neglected within a nanomaterial analysis. Also the degree of strain related with 
displacements, imperfections and internal tensions in the crystal lattice, usually 
observed when the peaks are dislocated or extended, can be disregarded in this case 
since we used a chemical method to synthesize nanoparticles. 
A diffractogram obtained with monochromatic radiation of a known wavelength 
has all the information to obtain the lattice parameter of the crystal, calculated by the 
quadratic formulae corresponding to the crystalline systems [31]. 
2.5.2. Transmission Electron Microscopy (TEM) 
Transmission Electron Microscopy (TEM) is a vital characterization tool for directly 
imaging nanomaterials to obtain quantitative measures of particle and/or grain size, size 
distribution, and morphology. 
The TEM operates on the same basic principles as the light microscope, but uses 
an electron beam interacting with the sample instead of light, and it is much more 
complex. Their transmission mode imposes a “transparency” of the sample to the 
electrons, thus the maximum thickness at the borders should be about 100 nm [32]. 
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In such instruments, the gun chamber generates a beam of high energy electrons 
which are accelerated by changing the electrical potential difference in the range 40 to 
400 kV. Then, this beam is collimated by magnetic lenses and allowed to overpass the 
sample under high vacuum. The obtained transmitted beam and several diffracted 
beams generate the image and also a diffraction pattern, which are displayed on a 
fluorescent screen located under the sample. The lattice spaces of the crystalline 
structure can be obtained from the diffraction pattern [32]. The several layers of 
components inside a TEM are shown in Figure 5. 
 
Sensors such as EELS (Electron Energy Loss Spectrometer) and EDS (Energy 
Dispersive X-ray Spectrometer) can be coupled to TEM, enabling chemical analysis of 
Figure 5. Schematic representation of the basic principle and components involved in TEM. 
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the sample and making this characterization technique go further than just outputting a 
high resolution magnified image of a sample [32].  
2.5.3. Dynamic Light Scattering (DLS) 
Dynamic light scattering (DLS) is a well-established technique used to determine 
the size and size distribution of molecules and particles suspended in a liquid, typically 
in the submicron region, with the latest technology measuring sizes lower than 1 nm. 
This technique is also called photon correlation spectroscopy (PCS) and quasi-elastic 
light scattering (QELS). The latter terms are more common in older literature. 
The DLS technique measures the Brownian motion related to the size of the 
particles. Brownian motion designates the random movement of particles due to the 
bombardment of the solvent molecules that surround them. The larger the particle, the 
slower the Brownian motion will be [33].  
The basic principle of DLS technique is based in Stokes-Einstein equation: 
𝐷h =
𝑘B𝑇
3𝜋𝜂𝐷𝑡
  ,                                                                     (6) 
where Dh is the hydrodynamic diameter to be determined, Dt the translational diffusion 
coefficient of the particles in the liquid, kB the Boltzmann’s constant, T is the absolute 
temperature and η is the viscosity of the liquid. The translational diffusion coefficient is 
found by dynamic light scattering and depends not only on the size of the particles 
“core”, but also on any surface structure, as well as the concentration and type of ions 
in the medium [33].  
In a DLS instrument, a laser beam is directed to the suspension and, when it 
interacts with particles, the light is scattered in several directions. The scattered light is 
a function of the hydrodynamic size and concentration of the sample and is detected on 
a photon detector connected to a correlator. The correlator compares the intensity of 
the scattered light in consecutive intervals of time and generates a correlation function 
[33]. The operation basis of DLS is shown in Figure 6. 
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This hydrodynamic diameter corresponds to the diameter of a sphere that has the 
same translational diffusion coefficient as the particle, and it is obtained from the 
correlation function by using the cumulant method. By fitting a polynomial of third 
degree to the logarithm of the intensity correlation function, the decay rate Γ is 
obtained. The decay rate is directly related to the diffusion coefficient Dt: 
Γ=q2Dt   ,                                                                      (7) 
where q is the wave vector, which is dependent of the scattering angle. 
Particles of different sizes scatter with different intensities in correlation with the 
scattering angle. Thus, there is an optimum angle of detection for each particle size. A 
high quality analysis should always be performed at several scattering angles (multiangle 
DLS). This becomes even more important in case of polydisperse samples with unknown 
particle size distribution, since at certain angles the scattering intensity of some particles 
will completely overwhelm the weak scattering signal of other particles, thus making 
them invisible to the data analysis at this angle [33].  
2.5.4. Fourier Transform InfraRed (FTIR) Spectroscopy 
This characterization technique was applied to characterize the type of coat of 
Fe3O4 nanoparticles by identifying the chemical groups/bonds present in the 
synthesized samples. 
The total internal energy of a molecule in a first approximation can be resolved 
into the sum of rotational, vibrational and electronic energy levels. Infrared 
Figure 6. Schematic illustration of the optical configuration of a DLS instrument. 
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spectroscopy is the study of interactions between matter and electromagnetic radiation 
(photons) in a wave number range of 400 to 4000 cm-1. These interactions induce the 
excitation of the vibration or rotation of molecules to a higher energy state and they are 
normally related with stretching deformations of interatomic bonds and bending 
deformations of the interbond angles [17]. 
The probability of a particular beam of infrared light to be absorbed by the sample 
depends on the actual interaction between its frequency and the molecule. In general, 
a frequency will be strongly absorbed if its photon energy coincides with the 
vibrational/rotational energy levels and force constants associated with interatomic 
bonds of the molecule [17].  
The FTIR spectrometer operates on a different principle called Fourier transform. 
The mathematical expression of Fourier transform can be expressed as:  
𝐹(𝑤) = ∫ 𝑓(𝑥)𝑒𝑖𝑤𝑥𝑑𝑥
+∞
−∞
 ,                                                   (8) 
where ω is angular frequency and x is the optical path difference. F(ω) is the spectrum 
and f(x) is called the interferogram. It is clear that if the interferogram f(x) is 
experimentally determined, the spectrum F(ω) can be obtained by using Fourier 
transform. The operation principle linked to the interferogram acquisition is 
represented in Figure 7 and it’s based on the operation mode of a Michelson 
Interferometer.  
 
 
 
 
 
 
 
 
 
Figure 7. Schematic diagram of a Michelson Interferometer. 
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The light source produces a light beam that is directed to the beamsplitter. Half of 
the light is reflected and half is transmitted but then, both are reflected in two mirrors. 
The two beams reaching the detector come from the same source and have an optical 
path difference determined by the positions of the two mirrors, i.e. they have a fixed 
phase difference. Therefore the two beams interfere constructively or destructively for 
a particular frequency depending on the positioning of the moving mirror. Due to the 
movement of this mirror, a sinusoidal signal (interferogram) will be detected with the 
same frequency as this movement occurs. Fourier transform is then computationally 
applied and a spectrum with the percentage of radiation absorbed/transmitted versus 
the wavenumber frequency of the incident radiation is obtained [34].  
The differences in the chemical structure (bonds) of materials gives rise to unique 
infrared spectra for each material, making possible the identification of substances 
present in the sample. 
2.5.5. Thermal Analysis 
Thermal analysis is a branch of materials science characterization methods that 
measure with high precision distinct properties of the sample (weight, volume, 
temperature, etc.) when this is subjected to heating with a programed profile (usually 
at a constant rate between 2 and 10oC.min-1). In order to characterize iron oxides, two 
main thermal analysis methods are commonly used: thermogravimetric analysis (TGA) 
and differential scanning calorimetry (DSC) [17]. 
TGA is a method of thermal analysis that precisely measures the weight of the 
sample as a function of increasing temperature (with constant heating rate), or as a 
function of time (with constant temperature and/or constant mass loss) [35]. Therefore, 
the basic instrumental requirements for TGA are a precise scale with a pan loaded with 
the sample, and a programmable furnace (Figure 8). As the temperature increases, the 
various components of the sample are volatilized/decomposed and the percentage of 
weight loss for each one can be measured. The first derivative is often also plotted to 
determine points of inflection for more in-depth interpretations and framing of the 
phenomena. 
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In DSC, an accurate measurement of the exchanged heat flow is made, as a 
function of temperature or time. With this thermoanalysis technique is possible to 
determine endothermic and exothermic events in the sample from the obtained peaks. 
These peaks are normally representative of phase changes in the sample or undergoing 
reactions [36]. For magnetite, thermograms show a first exothermic peak involving a 
phase transformation from magnetite (Fe3O4) to maghemite (ɣ-Fe2O3) – at 225 0C - and 
a second one (also exothermic) demonstrative of maghemite to hematite (α-Fe2O3) 
phase transformation – at 590 0C. 
In both methods, the experiments can be conducted in various atmospheric 
conditions, e.g., vacuum, inert, oxidative or reactive.  
2.5.6. Vibrating Sample Magnetometer 
A vibrating sample magnetometer (VSM) is a scientific instrument that measures 
magnetic properties of the materials such as the type, strength and direction of the 
remnant magnetization of magnetic materials. The creator of this characterization 
Figure 8. Schematic arrangement of a TGA equipment. 
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instrument was Simon Foner, in 1955, and despite of several possible detection-coil 
configurations existing nowadays, all of them (older and new) follow Faraday’s Law of 
Induction. This law states that an electromagnetic field is generated when a change in 
flux linking the coil is induced. 
 Thus, a coil with n turns of cross sectional area a can generate a electromotive 
force V described as: 
𝑉 =  −𝑛𝑎
d𝐵
d𝑡
                                                                  (9) 
being B the magnetic flux density. 
When the coil is positioned in a constant magnetic field, H: 
𝐵 =  µ0𝐻                                                                     (10) 
where µ0 is the vacuum permeability constant (4π x 10-7 N.A-2). 
If the sample with a magnetization M is introduced into the coil: 
𝐵 =  µ0(𝐻 + 𝑀)                                                            (11) 
The flux changes can now be expressed by: 
𝛥𝐵 =  µ0𝑀                                                                    (12) 
Combining the previous equations (10) and (13): 
𝑉𝑑𝑡 =  −𝑛𝑎µ0𝑀                                                            (13) 
From these equations, it can be concluded that the output signal of the coil is 
proportional to the magnetization of the sample (M) but independent of the magnetic 
Figure 9. Schematic configuration of VSM equipment [38]. 
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field applied to it (H) [37]. The fundamental schematic configuration of a VSM equipment 
is represented in Figure 9. 
 The operation mode involves a rod, where, in the nonmagnetic tip, a small sample 
is attached, and the other end is fixed to a linear motor, which makes the sample 
oscillate according to a desired frequency. This movement induces an electromagnetic 
field in the detection coil. 
Because of the small alternated electromagnetic field, it is required the use of a 
look-in amplifier with high sensitivity only at the frequency of vibration. It is important 
to highlight that this amplifier must be provided with a reference signal originated from 
a sensor coupled to the driving system, which makes the sample oscillate. 
When performing this analysis, the preparation of the sample must be done as 
clean as possible, because any amount of contaminating material can saturate the 
measurement of small amounts of magnetic materials. Other important aspect is the 
required calibration of the equipment, made with a specimen of known magnetic 
moment. This should have the same size and similar shape to the samples to be 
measured. 
Since magnetite and maghemite have higher magnetic susceptibility (χ) than any 
other iron oxides, their presence will dominate the magnetization characteristics [16]. 
Due to the versatility and sensitivity of VSM, it is used either for weakly or strongly 
magnetic materials [38]. 
2.5.7. Mössbauer Spectroscopy 
Mössbauer spectroscopy is a versatile technique used to study the nuclear 
structure of elements with the absorption and re-emission of gamma rays. This radiation 
is the most energetic of the electromagnetic spectrum. The technique uses a 
combination of the Mössbauer effect and Doppler shifts to probe the hyperfine 
transitions between the excited and ground states of the nucleus.  
The phenomenon of resonant absorption of gamma rays, without recoil of the 
nucleus (also known as Mössbauer effect), only occurs in solid-state when the nucleus 
of the element is rigidly fixed in the crystal lattice. Only a certain number of elements 
exhibit Mössbauer characteristics, e.g. Fe, Ni, Zn, etc. The most commonly used isotope 
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for iron is 57Fe. It is a non-destructive and reliable technique, offering high resolution of 
charge state, ordering temperature and magnetic moment direction [39]. 
In order to study Fe atoms, the application of this method of spectroscopy consists 
on a source with 57Co nuclei which decay by electron capture to an excited state of 57Fe 
and, then, to a ground state of 57Fe emitting the desired gamma-ray in the process. If 
the radiation is absorbed resonantly, the emitted gamma-ray can excite a transition in 
the sample being studied [15]. That interaction is then recorded by the computer as a 
point. When data acquisition finishes, a lorentzian approximation is performed to the 
scattered data, obtaining a Mossbauer spectra. In Figure 10, it is demonstrated how this 
method can be applied to obtain a Mössbauer spectra. 
In transmission geometry, a plot of relative absorption against the velocity of the 
source, having the absorber in a fixed position, is obtained from a Mössbauer 
measurement. Doppler effect is implied in this movement of the source, with the aim of 
varying the energy emitted by the Mössbauer gamma-ray (14.44 keV for 57Fe).   
 
There are 3 types of interactions between the emitted gamma-rays and the 
samples being studied: isomer shift, quadrupole splitting and hyperfine magnetic field. 
Depending on the nature of the sample to be studied, some interactions are more 
evident than others. At the origin of each hyperfine interaction there is a coupling 
between resonant nuclei and the electrons surrounding them [39]. The parameters 
obtained in the fitting of spectra are the hyperfine parameters, as it is described and 
illustrated in Table 3. 
 
Figure 10. Experimental assembly representation of Mössbauer spectroscopy in transmission geometry. 
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Table 3. Description and illustration of hyperfine interactions that occur in Mössbauer spectroscopy [17]. 
Name Description 
Isomer shift (δ) 
Shift in the resonance energy of the transition produced by an energy 
difference in the s-electron environment between the source and absorber. 
Depending on the s-electron density, this shift is positive or negative. 
Quadrupole splitting 
(ΔEQ) 
Interaction between the nuclear quadrupolar moment and an electric 
field gradient at the nucleus causes splitting of energy levels. 
Hyperfine magnetic 
field (H) 
Interaction of the dipole moment of the nucleus and the hyperfine 
magnetic field causes splitting of the nuclear energy levels. 
 
 
 
The number of peaks obtained in a Mössbauer spectrum is related to the solid 
state transitions allowed between the ground state 57Fe, and its excited state 57Fe*. 
Depending on the crystal arrangement of the sample, several absorption lines as 
function of source velocity can be observed. The central position of each line is given 
relatively to an arbitrary origin, which is frequently the centre of the spectrum and 
corresponds to a sample of metallic iron measured at room temperature. 
The magnetic properties of nanoparticles may differ from those of bulk materials, 
so when the size of the grains is too small, as it is expected for nanoparticles, the 
superparamagnetic character (relaxation effect of the magnetic state) of iron is shown 
by the presence of a single line centred near zero nm s-1. The most dramatic effect of a 
small particle size is the fluctuation of the magnetization direction, instead of being 
stable.  
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Due to the exponential dependence of the relaxation time on the energy barrier, 
kV, the distribution of sizes shown by a sample of magnetic nanoparticles results in a 
very broad distribution of relaxation times, and Mössbauer spectra may have sextets 
and doublets or singlets. Frequently, the broad components due to particles with same 
size have low relative area and they are barely visible in the spectra. The temperature 
dependence of the relaxation times implies a variation of the area ratio of the sextets 
and doublets or singlets with the temperature. 
The study of samples with a broad distribution of relaxation times, in Mössbauer 
spectroscopy, shows that the average blocking temperature is often defined as the 
temperature where half of spectrum is in a sextet and half of it is in a doublet or in a 
singlet form [39]. 
2.5.8. Zeta Potential 
The development of a net charge at the particle surface affects the distribution of 
ions in the surrounding interfacial region, resulting in an increased concentration of 
counter ions (ions of opposite charge to that of the particle) close to the surface. Thus, 
an electrical double layer exists around each particle. As it is shown in Figure 11, the 
liquid layer surrounding the particle exists as two parts: an inner region, called the Stern 
layer, where the ions are strongly bound, and an outer, diffuse, region where they are 
less firmly attached. Within the diffuse layer there is a notional boundary inside which 
the ions and particles form a stable entity. This boundary is called the surface of 
hydrodynamic shear or slipping plane and the potential that exists at this boundary is 
known as the Zeta potential [40]. 
The Zeta potential equipment calculates this propriety of particles by determining 
the electrophoretic mobility and then applying the Henry equation. The electrophoretic 
mobility is obtained by performing an electrophoresis experiment on the sample and 
measuring the velocity of the particles using Laser Doppler Velocimetry (LDV). The Henry 
equation connects this features and is expressed by: 
     𝑈E =
2 𝜀 𝑧 𝑓(𝑘𝑎)
3𝜂
  ,                                                      (14) 
where UE is the electrophoretic mobility, z the zeta potential, ε the dielectric 
constant, η the viscosity,  and f(ka) is the Henry’s function that, for small particles, takes 
an approximate value of 1,0 [41]. 
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The magnitude of the zeta potential gives an indication of the stability of the 
colloidal system. If all the particles in suspension have a large negative or positive zeta 
potential then they will tend to repel each other and there is no tendency to flocculate. 
However, if the particles have low zeta potential values, then there is no force to prevent 
the particles coming together and flocculating. Particles with zeta potentials more 
positive than +30 mV or more negative than -30 mV are normally considered stable [41]. 
In this equipment, a laser is used to provide a light source to illuminate the 
particles within the sample, being this light source splitted to provide an incident and 
reference beam. The reference beam is also ‘modulated’ to provide the necessary 
Doppler effect. The laser beam passes through the centre of the sample cell, and the 
scattering at an angle of 17° is detected. With insertion of the cell into the cell holder, 
the cell terminals allow the system to recognise the type of zeta potential cell fits, which 
configures the software to use the correct measurement sequence. When an electric 
field is applied to the cell, any particles moving through the measurement volume will 
cause the intensity of light detected to fluctuate with a frequency proportional to the 
particle speed. A detector sends this information to a digital signal processor. This 
information is then passed to a computer, where the software produces a frequency 
spectrum from which the electrophoretic mobility and, hence, the zeta potential are 
calculated. The intensity of the scattered light within the cell must be within a specific 
Figure 11. Representation of the electrical double layer. 
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range for the detector to successfully measure it; to provide this, an “attenuator” is used 
to reduce the intensity of the laser and hence reduce the intensity of the scattering. The 
configuration of a Zeta Potential equipment is represented in Figure 12. 
 
 
 
  
 
 
 
 
 
 
 
 
 
The most important factor that affects zeta potential is pH. A zeta potential value 
without a quoted pH is a virtually meaningless number. The point where the plot passes 
through zero zeta potential is called isoelectric point and is very important from a 
practical consideration. It is normally the point where the colloidal system is less stable.  
2.5.9. Lowry Method for protein quantification 
 The most accurate method for determining protein concentration is acid 
hydrolysis followed by amino acid analysis. However, most other methods are sensitive 
to the amino acid type of the protein, and absolute concentrations cannot be obtained 
[42]. The procedure of Lowry et al. [43] is no exception, but its sensitivity is moderately 
constant from protein to protein, and it has been so widely used that Lowry protein 
estimations are a completely acceptable alternative to a rigorous absolute 
determination in almost all circumstances in which protein mixtures are involved. 
The Lowry protocol is a two-step procedure. In a first step, a blue complex is 
produced by the reaction of the protein with Cu2+ ions in basic solution. In a second step, 
Figure 12. Configuration of a Zeta Potential equipment. 
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the intensity of the colour is enhanced by the reduction of phosphomolybdic-
phosphotungstic reagent (Folin-Ciocalteau reagent) by tyrosine and tryptophan.  
The implementation of this method needs the UV-Vis measurement of several 
samples with different protein concentrations in order to build a standard calibration 
curve that provides the obtainment of the protein concentration of the samples to being 
measured. All the procedures used in this method are further described in chapter 3. 
2.5.10. UV-Vis Spectroscopy 
As it was explained for FTIR spectroscopy (2.5.4), the spectroscopy is based on the 
study of the interaction between radiation and matter. This interaction causes in the 
atoms an electronic transition from a lower energetic level to a higher level due to 
energy absorption equal to the energy difference between both levels. Thus, UV-Visible 
spectroscopy (radiations with wavelengths between 10 and 1000 nm) provides 
information about the transition of the most external electrons of the atoms. Since 
different atoms or molecules absorb UV-visible radiation at different wavelengths, 
spectroscopy is massively used in analytical chemistry for the identification of 
substances through the spectrum emitted from or absorbed by them. This technique is 
also used to assess the concentration or amount of a given species using the Beer-
Lambert law [44].  
The Beer-Lambert law relates the absorption of radiation to the properties of the 
material through which it is passing through. It states that there is a logarithmic 
dependence between the transmission (or transmissivity), T, of light through a 
substance and the product of the absorption coefficient of that substance, α, and the 
distance the beam travels through the material (i.e. the path length), l. The absorption 
coefficient can, in turn, be written as a product of the molar absorptivity of the absorber, 
ε, and the concentration c of absorbing species in the material. For liquids, these 
relations are usually written as: 
    log 𝑇 = log
𝐼
𝐼0
= 𝜀𝑙𝑐 ,                                                           (15) 
where I and I0 are the intensity of the incident and the transmitted beams, respectively. 
The transmission can also be expressed in terms of absorbance (A): 
     𝐴 = − log 𝑇 .                                                            (16) 
So, Beer-Lambert equation can be written finally as: 
  
33 
 
     𝐴 = 𝜀𝑙𝑐 .                                                                    (17) 
 Either transmittance or absorbance can be measured experimentally with the 
spectrometer. Thus, if the path length and the molar absorptivity are known and the 
absorbance is measured, the concentration of the substance can be deduced. 
Commonly, both parameters are constant for a given set of experiments, thus, a plot of 
the sample absorbance against its concentration should be a straight line. In practice, a 
calibration curve is obtained by plotting the measured absorbance of a series of 
standard samples as function of their concentration. If the absorbance of an unknown 
sample is then measured, the concentration of the absorbing component can be 
determined from this graph [44]. 
The basic parts of a spectrophotometer are a light source, a sample holder, a 
diffraction grating or monochromator to separate the different wavelengths of light, and 
a detector. The radiation source is often a Tungsten filament (300-2500 nm) and a 
deuterium arc lamp which is continuous over the ultraviolet region (190-400 nm). The 
detector is typically a photodiode. Photodiodes are used with monochromators, which 
permit that only light of a single wavelength reaches the detector.  
A spectrophotometer can be either single beam or double beam. In a single beam 
instrument, all of the light passes through the same sample cell. First, the reference, Io, 
(generally the solvent) must be measured before the sample. This was the earliest 
design, but is still in common use in both teaching and industrial labs. In a double-beam 
instrument, the light is split into two beams before it reaches the sample. One beam is 
used as the reference and the other passes through the sample. Some double-beam 
instruments have two detectors (photodiodes), and the sample and reference beam are 
measured at the same time. A diagram of a double-beam UV-Vis spectrometer is 
represented in Figure 13. 
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Figure 13. Schematic of a double-beam UV-Vis Spectrometer. 
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3. Experimental Procedures 
This chapter briefly describes the used materials and procedures, as well as the 
characterization techniques applied during the entire experimental work that was 
performed. Throughout the course of this work the thermal decomposition technique 
was used for the synthesis of Fe3O4 nanoparticles. 
3.1. Materials 
Iron(III) acetylacetonate (Fe(C5H7O2)3, Fe(acac)3, 97%), oleylamine (C18H35NH2, 
70%), benzyl ether (C7H7OC7H7, 98%), hexane (C6H14,  ≥99%), cyclohexane (C6H12, ≥99%), 
toluene (C7H8, ≥99.5%), tetrahydrofuran (C4H8O, ≥99%), 1,4-dioxane(C4H8O2, ≥99%), 
bovine serum albumin (BSA, ≥98%), α-casein from bovine serum and Folin-Cicalteau’s 
phenol reagent  were purchased from Sigma-Aldrich.  
Sodium carbonate (Na2CO3, 98.8%) was bought from Gerbu and sodium hydroxide 
(NaOH, 98%) from PanReac AppliChem; copper sulfate (CuSO4.5H2O, 99%) and 
potassium sodium tartrate-4-hydrate (KNaC4H4O6.4H2O, 99.5%) were both purchased 
from Riedel-de Haën.  
Phosphate-buffered saline (PBS), polyoxyethylene 20 sorbitan monooleate 
(Tween 80 or Polysorbate 80, C64H124O26) and acetate buffer (pH = 3.6 and pH = 5) were 
produced and provided by investigators of Pharmaceutics Faculty of University of 
Coimbra. All presented reagents were used without any further purification. 
3.2. Synthesis of Fe3O4 nanoparticles  
4. Independently of the synthesis conditions that were used throughout the course 
of this thesis, which are posteriorly explained, Fe3O4 nanoparticles were always 
synthesized using the same experimental method – thermal decomposition – and 
assembly (Figure 14). Since this method requires high temperature, reflux was always 
used to condensate the released volatile gases. 
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The properties of the final nanoparticles may vary (particularly at nanoscale) due 
to small changes associated with: the equipment used in the experimental assembly, 
such as the inability to keep the heating mantle at a fixed temperature or the constant 
heat loss associated with the assembly; and details of procedures, such as the flow 
amount of N2, the maintenance of temperature thresholds and the stirring speeds of the 
magnetic stirrer. To avoid these types of variations in nanoparticles characteristics, the 
levels of the N2 flow and the stirring speed were controlled, as well as the temperature 
of heating mantle. Also, some renewable cotton jackets were used in order to prevent 
heat losses. 
3.2.1. Procedures A, B and C 
Initially, three major different procedures of synthesis were used: A, B and C. 
These were adjusted from the one used by Xu et al. [45] with changes on the amount and 
concentrations of the reagents. 
Figure 14. Real (left) and schematic (right) experimental assembly used in the synthesis of Fe3O4 
nanoparticles. 
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In procedure A, 1 mmol of iron (III) acetylacetonate, 4 ml of oleylamine and 1ml of 
benzyl ether were added into a 3 neck round-bottom flask. Then, the mixture was 
magnetically stirred and put under a flow of N2 during the reaction, in order to ensure 
an inert atmosphere that avoids the nanoparticles oxidation [45].  
The temperature of the reactor was then increased and two thresholds of 
temperature were established: the first at 110 oC, during 75 minutes, for the formation 
of nuclei - nucleation process, and the second during 45 minutes at 300 oC, for the 
growth of nanocrystals. The first threshold was achieved at a heating rate of 10 oC min-
1 and the second one was reached at 16oC min-1. Finally, the mixture was let to cool 
down until room temperature. 
The two remaining procedures, B and C, were variations of the first (A), in order 
to investigate the effect of changing the initial ratio of oleylamine/benzyl ether in the 
resulting nanoparticles characteristics. This was made by changing the initial volumes of 
oleylamine and benzyl ether as summarized in Table 4. 
  
3.2.2. Procedures A+A, B+B and C+C 
In the A+A, B+B and C+C variations of the above procedures, before adding the 
iron (III) acetylacetonate to the respective volumes of oleylamine and benzyl ether into 
the 3 neck round-bottom flask, previously synthesized Fe3O4 nanoparticles were dried 
inside the reactor. This new approach was applied in order to achieve a larger size of the 
synthesized SPIONs, by using them as seeds [46] and expecting that no more nuclei would 
be created and the added Fe(acac)3 would be used only for the nanocrystals growth. The 
temperature thresholds, time steps and heating rates were maintained as described 
before. 
Table 4. Volumes of oleylamine and benzyl ether and corresponding ratios used in procedures A, B 
and C. 
Procedure 
Volume of oleylamine 
(ml) 
Volume of benzyl ether 
(ml) 
oleylamine/benzyl ether Ratio 
(V/V) 
A 4 1 4:1 
B 2.5 2.5 1:1 
C 1 4 1:4 
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3.2.3. Procedures A*, B* and C* 
These 3 procedures consisted in the variation of the time during which the second 
threshold of temperature was maintained. Thus, 1 hour was added in this part of the 
synthesis experiment, in order to better understand the impact that the increase of 
nanocrystals growth time in the nanoparticles size. A shorter time was not tested, as the 
original nanoparticles were already very small. 
3.2.4. Procedures A(2x), B(2x) and C(2x) 
Procedures A(2x), B(2x) and C(2x) were used with the objective of evaluating the 
influence of iron(III) acetylacetonate amount in the SPIONs size, shape and magnetic 
characteristics. As the name designations suggest, the initial amount of Fe(acac)3 was 
doubled – 2 mmol was used. The volumes of oleylamine and benzyl ether that were used 
were the same as defined in Table 4. The remaining conditions/steps were the same as 
described in section 3.2.1. 
3.2.5. Purification method 
When the room temperature was achieved, the obtained mixture was dispersed 
in ethanol and centrifuged at 7000 rpm for 15 min. This separation process was repeated 
until a clear separation between the deposited nanoparticles and ethanol was observed.  
3.2.6. Storage method 
As hexane is a very polar solvent, it forms a highly stable nanofluid with the 
synthesized hydrophobic nanoparticles, and easily evaporates at room temperature. 
Thus, the deposited nanoparticles were re-dispersed in this solvent and stored in the 
refrigerator. 
The obtained nanofluid was so stable centrifugation process proved to be 
inefficient to separate particles from hexane. So, this storage method can be applied 
until the synthesized nanoparticles are re-dispersed in water for future applications in 
human cells. Dispersion in water is only possible after coating the Fe3O4 nanoparticles 
with a surfactant, process that will be explained in the next section.  
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3.3. Stabilization of Fe3O4 nanoparticle suspensions 
Nanoparticles are obtained and suspended in organic solvents. In order to 
evaluate the cytotoxicity of the nanoparticles in cell cultures, the organic solvent needs 
to be replaced by a non-cytotoxic solvent. With this objective, the particles were 
centrifuged and the supernatant was replaced by a compatible physiological buffer, like 
phosphate buffer saline (PBS). Compounds with surfactant properties were included on 
buffer composition to improve the physical stability of the suspension. 
Tween 80 and bovine serum albumin (BSA) were tested as surfactants, mixing 
them in different concentrations with PBS. The surfactant concentrations ranged 
between 1% and 3% for BSA in PBS and from 1% to 5% for Tween 80 in PBS.  
4 ml of the stored Fe3O4 nanoparticle suspensions were dried in glass cuvettes, 
letting hexane evaporate. Then, 4 ml of each surfactant mixture were added as re-
suspension solvent and an ultrasonic bath was applied to homogenize those 
suspensions. Posteriorly, the new re-dispersed suspensions were let rest for 8 h to 
evaluate suspension stability, i.e. Fe3O4 nanoparticles deposition. Additionally, UV-Vis 
spectroscopy technique was applied (see 3.5.10.) in order to conclude about which 
surfactant solution allows a better stability of the Fe3O4 nanoparticle suspension. 
3.4. Fe3O4 nanoparticles loading with α-casein and BSA 
BSA and α-casein were chosen as model protein due to their isoelectric point (4.7 
and 4.2-4.7, respectively). The protein loading of the SPIONs was firstly tested by directly 
mixing the protein aqueous solution and the stored hydrophobic nanoparticle 
suspension [47]. Since this loading process formed large clusters, due to the 
incompatibility of those components, a surfactant solution of PBS with Tween 80 was 
used to re-suspend the nanoparticles. This process increases the surface area available 
for protein adsorption and favors the interactions between the nanoparticles and the 
protein and, subsequently, may increases the protein adsorption. 
The protein adsorption was quantified using an experimental procedure for 
protein quantification known as Lowry protein assay (see 2.5.9.) also described in detail 
later (3.5.11.). 
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3.5. Characterization techniques/procedures 
3.5.1. X-Ray Diffraction (XRD) 
The stored suspensions of nanoparticles could not be directly measured due to 
the presence of the liquid phase (hexane). For that reason, a procedure was developed 
that allowed a proper analysis of the nanoparticles which consisted in using a Pasteur 
pipette to deposit droplets of the solution in a microscope slide that had a parafilm 
mask. For each droplet deposited, hexane was let to evaporate. This process was 
repeated for 10 mL of the stored suspension with a concentration of 3.34 mg ml-1, and 
a black-brown oily layer adhered to the glass. It was required an homogeneous 
deposited layer, but that process revealed to be difficult so the parafilm mask  was 
essential to avoid the formation of a thin and heterogeneous layer. In the end of the 
microscope slide preparation, the mask was carefully removed. 
X-ray patterns were recorded in a Bruker 8D Advance diffractometer working with 
40 kV and 40 mA using a Ni-filtered Cu kα radiation (λ = 0.154184 nm) in a  𝜃 − 2𝜃 
configuration of Bragg-Brentano geometry. The acquisition was usually in the  2𝜃 range 
of 10-120o with a step of 0.03o and acquisition time for each step of 10 s. The 
diffractometer belongs to TAIL platform of University of Coimbra, installed at the 
Department of Physics. The software used to refine the cell parameters were TOPAS and 
EVA (both part of the Bruker diffractometer package). 
The different phases present in the analyzed samples were identified by 
comparison of the XRD patterns with the ones stored in PDFs (Powder Diffraction Files) 
database from ICDD. The data of the diffractograms was compared with a calculated 
model (Pawley method), that is used to profile refinement and intensity extraction of 
powder diffraction data, constrained only by lattice parameters and FWHM distribution. 
3.5.2. Transmission Electron Microscopy (TEM) 
The procedure for implementation of this characterization technique involved a 
deposition of 25 µl of nanoparticles dispersion in a Cu microgrid, followed by drying 
during 30 seconds, and addition of a radioactive contrasting agent to allow a good 
quality image. This radioactive contrasting agent was also dried for 2 minutes. The 
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concentration of the sample was very low, to assure its electron transparency and, 
consequently, a micrograph with measurable data. 
The TEM equipment used for the analysis of the nanoparticles size was a Jeol JEM 
1400 transmission electron microscope, belonging to IBMC in Porto. This TEM is a 120 
KV instrument, with a magnification range of 50X – 2 000 000X and resolution of 0.20 
nm (lattice image). In the case of the tested samples, a magnification of 300 000X was 
applied. 
3.5.3. Dynamic Light Scattering (DLS) 
This characterization technique was used in order to evaluate the hydrodynamic 
diameter of the synthesized Fe3O4 nanoparticles. The necessary procedure for this 
characterization technique required an initial dilution of the original stored suspensions 
(one droplet of the nanoparticles suspension in 30 ml of the re-dispersive solvent) and 
a filtration of the nanoparticles agglomerates with a syringe filter of 450 µm. The diluted 
suspension was filtered into a glass cuvette and then applied in the DLS equipment. 
According to the report of count rate and approximation of the measuring models of the 
equipment, the sample to be measured was even more diluted or concentrated, with 
addition of more re-dispersive solvent or more droplets of the initial stored suspension, 
respectively. 
 Due to the inaccurate results obtained with hexane as re-dispersant solvent (see 
next chapter), others apolar solvents such as toluene, cyclohexane, 1,4-dioxane and 
tetrahydrofluran were used for that purpose. Independently of the solvent used, all 
procedures for this characterization technique were maintained. 
A Zetasizer Nano ZS from Malvern Instruments was used for the analysis, 
equipment that belongs to the Chemical Engineering Department of the University of 
Coimbra. It allowed a size measurement range from 0.3 nm (diameter) to 10 µm using 
patented NIBS (Non Invasive Back scatter) technology. This equipment has a working 
range temperature between 0 to 90 °C and a He-Ne laser as light source. The used 
software was Zetasizer, part of the equipment package, applied to evaluate the 
measurement parameters. 
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3.5.4. Fourier Transform Infra-Red Spectroscopy (FTIR) 
This characterization technique was applied to identify the chemical groups/bonds 
present in the synthesized Fe3O4 nanoparticles. To accomplish that purpose, a FT/IR 
4200 spectrometer from Jasco was used, selecting a wavenumber range of 4000-400 
cm-1 with 4 cm-1 of resolution. The FTIR equipment that was used belongs to the 
Chemical Engineering Department of the University of Coimbra.  
Initially, KBr was milled until a fine powder was obtained and, then, it was dried in 
an oven at 60oC for 2 days. After that, 30 µl the sample were added to 79/80 mg of KBr 
powder, mixing them until a homogeneous powder was obtained. The mixture was then 
pressed to obtain a small, thin and translucent pellet for the analysis. Between each 
pellet, the mold was carefully cleaned to avoid contamination and inaccurate results.  
Before acquiring the spectra of the samples a base line was built with a KBr pellet 
without sample in the equipment support. Then, the pellet with nanoparticles was 
placed in this support and the transmittance variation was recorded, according with the 
wave number of the incident radiation [48].    
3.5.5. Thermal Gravimetric Analysis (TGA) 
With the aim of quantifying the percentage of organic coating on the synthesized 
nanoparticles, thermal gravimetric analysis was applied. Similar to the XRD procedure, 
the stored suspensions of nanoparticles couldn’t be directly measured due to the 
presence of the liquid phase. Thus, the same procedure of depositing the sample 
droplets in a microscope slide was applied.  
When the samples of Fe3O4 nanoparticles were fully dried, they were transferred 
to the aluminum crucible of the measuring instrument. The used instrument was a TGA 
Q50, from TA Instruments. Its field-proven performance arises from a responsive low-
mass furnace, ultra-sensitive scale, and efficient horizontal purge gas system (with mass 
flow control).  So, under a nitrogen atmosphere, the samples were heated from room 
temperature to 600 °C, at a rate of 10 °C min-1.  
The obtained results were treated with the software of the instrument, TA 
Universal Analysis, which allows the graphical observation of the weight of the samples 
(or derivative) as function of its temperature. 
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3.5.6. Vibrating Sample Magnetometer (VSM) 
This important characterization technique involved a drying procedure of the 
stored nanoparticles similar to the one applied for XRD and TGA procedures. The dried 
material was then weighted and placed in the powder sample support. The support was 
sealed and thoroughly cleaned to assure that there was not contaminating material that 
could saturate the measurement of weakly magnetic samples. 
The sample support was placed in a rigid tube that vibrates vertically and the 
correct position of the sample was determined by a scanning in the sensitive zone of the 
magnetic coils. After this procedures, the M(T) and M(H) curves were obtained. The 
thermal dependence of the magnetisation was measured in zero-field cooled (ZFC) and 
field cooled (FC) curves under applied fields of 50 and 100 Oe. The hysteresis cycles 
where measured at room and low temperatures. 
The magnetic measurements were performed in a VSM, with a cryogen-free 
Physical Properties Measurement System (PPMS Dynacool Quantum Design). The VSM 
belongs to TAIL platform of University of Coimbra, installed at the Department of 
Physics. 
3.5.7. Mössbauer Spectroscopy  
Mössbauer spectra were recorded at T=30 K with a conventional transmission 
geometry spectrometer with constant acceleration. The source was 57Co in Rh matrix 
with a strength of 10 mCi. The fitting of spectra was done with Lorentz lines using the 
NORMOS program distributed by Wissel, Germany. Isomer shifts are given, as usually, 
relatively to α–Fe measured at room temperature. 
The samples were dried in vacuum and, then, placed in a perspex sample holder. 
The cryostat used was a closed-cycle system of low pressure helium gas, and is 
composed of several modules of “Air Products and Chemicals, Inc”, like a compressor 
module, an expander module and a refrigeration system where the sample is placed. 
This spectrometer and cryostat belong to CFisUC at Department of Physics of 
University of Coimbra.  
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3.5.8. Evaluation of the cytotoxicity 
In order to perform these tests, the nanoparticles synthesized by procedures C(2x) 
and C were dried, weighted, UV-sterilized and dispersed in DMEM (culture medium), 
with 0.5% of Tween 80 which increased their stability in the suspension with a sonicate 
process for 60 s.  
Then, cos-7 cells were seeded in a 96-well plate at a density of 1x105 cells/well in 
100 µl of DMEM and incubated 24 h. In the next day, medium was replaced by the same 
value of fresh medium and formulations were added to a final concentration from 0.975 
to 2000 µg/ml of nanoparticles in each well. After incubation for 24 h at 37 °C, 20 µl of 
MTT 5mg ml-1 in PBS (pH=7.4) was added to each well and incubated for more 2 h at 37 
°C. Then, the medium was removed and formazan crystals produced by metabolic active 
cells were solubilized with 200 µl of DMSO per well. In order to deposit the Fe3O4 
nanoparticles, an 800 g (RCF) centrifugation was performed for 15 minutes and the 
optical density (OD) of the supernatant was measured at 540 nm with 630 nm as 
wavelength reference using a microplate spectrophotometer (Thermo Scientific 
Multiskan EX). 
The viability of non-treated cells (control) was defined as 100% and the relative 
cell viability (%) calculated using the equation: 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =
𝑂𝐷 𝑠𝑎𝑛𝑝𝑙𝑒(540 𝑛𝑚)−𝑂𝐷 𝑠𝑎𝑚𝑝𝑙𝑒 (630 𝑛𝑚)
𝑂𝐷 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 (540 𝑛𝑚)−𝑂𝐷 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 (630 𝑛𝑚) 
 × 100                       (18) 
3.5.9 Zeta Potential 
Aiming to quantify the surface charge of the obtained Fe3O4 nanoparticles in 
several mediums, the measurement of the zeta potential was performed. The 
application of this characterization technique involved similar procedures to the ones 
applied in DLS. In fact, some of the measurements were done in the same instrument as 
DLS, Zetasizer Nano ZS, from Malvern Instruments (Chemical Engineering Department 
of the University of Coimbra). Other measurements were obtained with Delsa Nano C 
Particle Analyzer from Beckman Coulter (Pharmaceutics Faculty of University of 
Coimbra). 
The Fe3O4 nanoparticles dispersed in PBS (6.66 mg/ml) were re-dispersed in water, 
PBS and acetate buffer using a dilution factor of 10 (100 µl:1 ml). Approximately 500 µl 
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of these re-dispersions were put in the specific cell for Zeta potential measurement. 
Between the analyses of samples the cell was carefully washed with water to prevent 
any type of contamination.  
3.5.10. UV-Vis Spectroscopy 
The measurement of transmittance of the SPIONs dispersions allows an evaluation 
of their stability in the used solvents (see 3.3.). Furthermore, it can also give us a way to 
quantify the amount of protein adsorbed by the obtained Fe3O4 nanoparticles (see 3.4.). 
The UV-Vis spectroscopy was applied with both purposes. 
To evaluate the stability of SPIONs dispersions, a T70 UV-VIS spectrophotometer 
from PG Instruments was used, which belongs to Chemical Engineering Department of 
the University of Coimbra. It required 4 ml of sample to fill the quartz cuvette. In 
addition, an automatic electronic background subtraction was needed, known as auto-
zero procedure, for which only the dispersion agents were used. The samples to be 
measured were composed of those dispersion agents, PBS with BSA (1-3%) or Tween 80 
(1-5%), and the synthesized SPIONs with a concentration of 6.66 mg/ml. For each 
sample, a spectrum of transmittance (%) as function of wavelength acquired using the 
UV Win5 software of the equipment. 
In order to extrapolate the amount of protein adsorbed by Fe3O4 nanoparticles, 
the absorbance at 750 nm of some samples was measured according to the Lowry 
method (see 2.5.9. and 3.5.11.). That process was performed in a Shimadzu UV 1603 
spectrophotometer belonging to Pharmaceutic Faculty of University of Coimbra.  
3.5.11. Lowry Method for evaluation of efficacy of protein 
adsorption 
The application of this method for protein quantification required a specific 
protocol that has many variations of Lowry procedure depending on the laboratory. The 
procedures here described and applied were used for protein quantification of solutions 
of α-casein and BSA in different concentrations, where the stored nanoparticles were 
re-dispersed. The amount of protein in the supernatant was measured (after a 
centrifugation process) to be able to determine the efficiency of bonding of the protein 
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to the nanoparticles (loading efficiency) and the capacity of nanoparticles to be loaded 
by the protein (loading capacity). These properties can be determined by : 
𝐿𝑜𝑎𝑑𝑖𝑛𝑔 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%) =
𝑚𝑖(𝐵𝑆𝐴)− 𝑚𝑠(𝐵𝑆𝐴)
𝑚𝑖(𝐵𝑆𝐴)
× 100                             (19) 
   𝐿𝑜𝑎𝑑𝑖𝑛𝑔 𝐶𝑎𝑝𝑎𝑐𝑖𝑡𝑦 (µ𝑔/𝑚𝑔) =
𝑚𝑖(𝐵𝑆𝐴)− 𝑚𝑠(𝐵𝑆𝐴)
𝑚(𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠)
                                   (20)  
being mi(BSA) the initial mass of BSA (µg/ml), ms(BSA) the mass of BSA in the surfactant 
(the measured property - µg/ml) and m(nanoparticles) the mass of nanoparticles in the 
dispersions (mg/ml). 
For that, an adapted protocol[49] was performed, where the Lowry reagent was 
prepared fresh each day composed by 1 ml of sodium carbonate (370 mM), 800 µl of 
sodium hydroxide (245.25 mM), 100 µl of copper sulfate (7.8 mM) and 100 µl of 
potassium sodium tartrate-4-hydrate (14 mM) that were thoroughly mixed. Then, 
several dilutions were done of α-casein/BSA protein standard solution (5.0 mgml-1) in 
acetate buffer (pH=5)/water, according to Table 5. From the 500 µl of each dilution, 200 
µl of them were mixed with another 200 µl of Fe3O4 nanoparticles (1 mg/ml), already re-
dispersed in acetate buffer or water with 0.1% of Tween80. These samples were mixed 
for 30 minutes and then centrifuged at 2300 rpm for 20 minutes, in order to remove and 
analyse the supernatant.  
For 200 µl of each supernatant sample and α-casein/BSA standard protein 
dilutions, 2 ml of the Lowry reagent (previously prepared) was added and the suspension 
was allowed to stand for 10 minutes at room temperature. After, 100 µl of Folin-
Cicalteau reagent was added to each sample and immediately mixed thoroughly.  
Table 5.α-casein/BSA standard protein stock solution dilutions. 
Stock solution (µl) 0 2.5 5 10 20 30 40 50 60 70 
Acetate Buffer/Water (µl) 500 497.5 495 490 480 470 460 450 440 430 
[protein] (µg/ml) 0 25 50 100 200 300 400 500 600 700 
 
The absorption measurements at 750 nm were done after letting the samples 
stand for 20 minutes at room temperature. First, a plot curve of absorption at 750 nm 
versus α-casein/BSA standard protein content (µg/ml) was obtained and, then, the 
unknown protein content of each sample was calculated by using with the equation of 
the linear function obtained with the protein standards. 
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4.  Discussion of SPIONs’ characterization results – Physicochemical 
Aspects 
In this chapter we will present and discuss the physicochemical characterization 
of all the synthesized SPIONs samples by applying the techniques described in the last 
chapter. Once we reach the end of this chapter, almost all of the different procedures 
and paths followed during the synthesis work will hopefully be clarified. Only the 
discussion of the results of their biological application will remain, which is presented in 
chapter 5. 
4.1. Standard Mössbauer spectra of magnetite and maghemite 
In order to draw a comparison between the synthesized materials using different 
procedures, some considerations about the standard Mössbauer spectra of magnetite 
and maghemite must be known and taken into account. This information will allow a 
proper analysis of the spectra obtained for those synthesized materials. 
4.1.1. Magnetite Mössbauer spectra 
At room temperature (RT), 57Fe Mössbauer spectrum of magnetite shows 2 
magnetic sextets, which strongly overlap (Figure 15). These sextets arise from the iron 
atoms in tetrahedral sites and in octahedral sites, respectively. There are also fast 
electron changes between Fe2+ and Fe3+ ions in octahedral sites providing time average 
species with only one magnetic sextet. The magnetic hyperfine fields are 49.0 T and 46.0 
T [50]. 
 
Figure 15. Mössbauer spectrum of natural magnetite at RT [51]. 
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The spectrum of magnetite at 4.2 K (Figure 16), is commonly fitted with 5 sextets, 
but because of the lack of resolution, different models can be proposed. The model 
using 5 sextets was proposed by Berry et al. [53]. Four components correspond to Fe3+ 
and Fe2+ situated two non-equivalent octahedral sites of the inverse spinel-related 
structure, while the remaining one corresponds to Fe3+ on the tetrahedral sites. This 
spectrum has a very characteristic line at ~-3.5 mm/s. 
 
 
Since nanoparticles have superparamagnetic behaviour and their magnetic 
properties can differ, depending on particle size and on the type of interactions between 
them, the spectra may be very complex [54].  
The Mössbauer spectra recorded at different temperatures for magnetite with 
particle size of 5 nm is shown in Figure 17. The fitting of the 16 K spectrum with 5 
magnetic sub-spectra results in hyperfine fields between 51.4 T and 43.9 T [54]. 
Figure 16. Mössbauer spectrum of natural (well crystalized) magnetite taken at 4.2 K [52]. 
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From these spectra analysis, with an increase of temperature, it is visible the 
fading of the sextets and the appearance of a centred singlet.  
4.1.2. Maghemite Mössbauer spectra 
Figure 18 shows the 57Fe Mössbauer spectrum of maghemite recorded at RT. This 
spectrum exhibits 2 magnetically split sextets with a small difference of the internal 
magnetic fields: 50.2 T and 50.5 T [51]. 
Figure 17. 57Fe Mössbauer spectra of magnetite with particle size of 5 nm for several 
temperatures [54]. 
Figure 18. 57Fe Mössbauer spectrum of pure (well crystallized) maghemite taken at RT [54]. 
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Figure 19 presents a typical spectrum of pure and crystalline maghemite obtained 
at 8 K. The asymmetry in the line depths should be noted, with the leftmost peak being 
narrower and deeper than the rightmost one. The spectrum can also be fitted with 2 
sextets with internal magnetic fields of 48.0 T and 51.5 T [55]. 
 
 
As it will be shown in Figure 20, the spectrum taken at RT of nanoparticles with 
small sizes consists only of a central paramagnetic doublet, with parameters: IS = 0.33 
mm/s and QS = 0.67 mm/s. The spectrum also shows a broad band [54]. At 16 K, the 
spectrum indicates the existence of 2 sextets with hyperfine fields of 51.7 T and 49.2 T. 
Small particle size decreases the hyperfine fields below that of bulk material and broad 
resonance lines [56]. However, direct comparison cannot be done by using these values 
with the values of bulk samples given above, because the spectra were taken at different 
temperatures.  
Figure 19. Mössbauer spectrum of pure (well crystallized) maghemite taken at 8 K [55]. 
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The separation between magnetic nanoparticles has an important influence in the 
magnetic dynamics due to the existence, or not, of magnetic particle interactions. 
Furthermore, the temperature dependence of the magnetic hyperfine field is also 
different for interacting and non-interacting nanoparticles, and the size of the magnetic 
hyperfine field is higher for interacting nanoparticles. 
In this work, magnetite would be preferred over maghemite for the target 
application due to its higher saturation magnetization and susceptibility, saturating at 
lower magnetic fields. Given the significant broadening of the nanocrystalline character 
of the samples and the existence of a particle size distribution and changeable 
proportions of magnetite and maghemite in each sample produced in this work, data of 
spectra are difficult to analyse and must be carefully treated.  
Figure 20. Mössbauer spectra of maghemite with particle size of 5 nm for different temperatures [54]. 
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4.2. Influence of the time for nanocrystals growth on the 
characteristics of the obtained iron oxide nanoparticles   
We begin by presenting and discussing the characteristics of the synthesized 
SPIONs from the starting procedures – A, B and C, followed with the characteristics of 
nanoparticles synthesized by the procedures A*, B* and C*, in which the time for 
nanocrystals growth was lengthen by 1 hour. Our goal slightly increase the nanoparticles 
size and verify the effect of this change in the magnetic yield, while optimizing the used 
oleylamine/benzyl ether ratio. Considering this challenge, the procedures that provide 
the most promising properties will be selected to pursuit the study. 
Figure 21. Diffractograms for samples obtained by procedures A and A*. 
Figure 22. Diffractograms for samples obtained by procedures B and B*. 
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Figure 21, 22 and 23 show the diffractograms obtained by the XRD analysis of the 
samples A, A*, B, B*, C and C*. The main purpose was to calculate their lattice parameter 
(considering a cubic structure) and crystallites size. The diffractograms presented very 
broad lines, due to the yield nano-sized particles from all procedures, and their pattern 
is very similar when comparing the different samples. The peak exhibited in Data C of 
Figure 23 for 2θ=27.3o is related to an interference of the sample holder, which was 
made of aluminium. Table 6 presents the results obtained for the lattice parameter (a) 
and crystallites sizes (D) for the synthesis procedures under comparison. 
 
Table 6. XRD derived results for the lattice parameter and crystallites size of nanoparticles produced 
by procedures A, A*, B, B*, C and C*. 
Procedure A A* B B* C C* 
a (nm) 0.83540(11) 0.83677(31) 0.83771(14) 0.83357(27) 0.83613(34) 0.83598(35) 
D (nm) 6.85(81) 6.85(16) 6.53(14) 5.22(14) 6.36(20) 5.33(14) 
 
Knowing that the reference value of the lattice parameter for maghemite is 
a=0.8347 nm, and for magnetite is a=0.8396 nm, the results exhibited in Table 6 show a 
mixture of both maghemite and magnetite for all procedures except for procedure B* 
that presents a dominant contribution of maghemite. There is a decrease in the value of 
the lattice parameter and crystallite size for B* and C* when compared to their 
Figure 23. Diffractograms for samples obtained by procedure C and C*. 
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respectively native procedures (B and C). The same didn’t happen for A*, where the 
crystallite size remained unchanged and the lattice parameter increased, suggesting an 
increase of magnetite content for this procedure.   
When the DLS technique was applied to measure the hydrodynamic diameter of 
the nanoparticles prepared by these procedures, there were some complications due to 
the solvent used for re-dispersions. There was a fast deposition of nanoparticles when 
hexane was used as dispersing medium, leading to incorrect measurements. 
Furthermore, a high variation of intra-sample sizes, a clear agglomeration for the 
majority of samples and a bad adjustment of the measurement models was verified. For 
these reasons, some other re-dispersive agents were tested: tetrahydrofuran (THF), 1,4-
dioxane, toluene and cyclohexane. Only the last one allowed a proper measurement of 
the hydrodynamic diameter of the prepared nanoparticles and the acquired results are 
presented in Table 7. 
 
Table 7. Hydrodynamic diameter measured by DLS for the nanoparticles obtained by procedures A, 
A*, B, B*, C and C*. 
Procedure Hydrodynamic diameter (nm) 
A 15,5 ± 1.9 
A* 19.2 ± 5.4 
B 19.1 ± 7.2 
B* 12.0 ± 3.7 136.1 ± 30.3 
C 18.7 ± 3.1 
C* 32.9 ± 3.4 152.6 ± 21.6 
 
DLS results show a small change of nanoparticles size of nanoparticle between 
samples prepared from procedures A and A*, and a clear agglomeration of nanoparticles 
synthesized from procedures B* and C*. This agglomeration is clear by the existence of 
two equal intensity peaks, whose diameters are represented in the table. It is worth 
nothing that, by the results presented in Tables 6 and 7, it can be concluded that each 
nanoparticle is constituted, at least, by 2-3 crystallites.  
Since the DRX and DLS results for the nanoparticles synthesized by the procedures 
A*, B* and C did not reveal a significant increase in size of crystallites and/or 
nanoparticles or in the amount of magnetite, it was concluded that increasing the time 
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of growth of nanocrystals had not the desired effect. On the other hand, it may cause 
agglomeration during the synthesis. This agglomerative effect of nanoparticles 
enhances their cytotoxic effect and, theoretically, reduces the drug absorption as the 
area/volume ratio is decreased.   
By this point, procedures A*, B* and C* were abandoned as they did not lead to 
high quality and size-controlled superparamagnetic iron oxide nanoparticles with the 
necessary characteristics for drug delivery in brain. It was not possible yet to choose 
between procedures A, B and C, with the present results, but procedures A and C seem 
to be the ones with larger size of nanoparticles.  
  
4.3. Influence of the addiction of seeds in the synthesis process 
(two stage-process) on the nanoparticles characteristics 
Based on procedures A, B and C, procedures A+A, B+B and C+C were developed. 
As it was described in the experimental work, these procedures used previously 
synthesized nanoparticles as nuclei/seeds (nucleation targets) for the next synthesis, 
hoping that no more nucei were created, and the added Fe(acac)3 was used in the 
nanocrystals growth. Once again, the criteria for the selection or rejection of the suitable 
procedures were mainly the obtained phase(s) and particle size. 
 
 
Figure 24. Diffractograms for samples obtained from procedures A and A+A. 
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Diffractograms of Figures 24-26, obtained for the referred samples continue to 
have very broad lines due to the yield nano-sized particles of all methods. The peak 
exhibited in Data C and Data C+C of Figure 26 for 2θ=27.3o is related to the sample 
holder, as it was described in Section 4.2. Besides that, the diffractograms show no 
significant difference between the position and shape of peaks for the samples 
compared in each figure, but the peaks intensity and the calculated lattice parameter 
change. Table 8 presents the results of nanoparticles calculated from DRX for the 
synthesis procedures under comparison. 
 
Figure 25. Diffractograms for samples obtained from procedures B and B+B. 
Figure 26. Diffractograms for samples obtained from procedures C and C+C. 
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Table 8. XRD derived results for the lattice parameter and crystallites size of nanoparticles produced 
by procedures A, A+A, B, B+B, C and C+C. 
Procedure A A+A B B+B C C+C 
a (nm) 0.83540(11) 0.83624(53) 0.83771(14) 0.83699(12) 0.83613(34) 0.83785(18) 
D (nm) 6,.5(81) 5.62(14) 6.53(14) 9.99(14) 6.36(20) 7.640(76) 
 
When we observe the values of the lattice parameter of each sample (Table 8), it 
is obvious that these values are between the reference ones for maghemite (a=0.8347 
nm) and for magnetite (a=0.8396 nm), confirming the existence of a mix of the two iron 
oxides in these samples. A closer look lets us conclude that, except for procedure A+A, 
the crystallite size of the samples B+B and C+C increased when compared to the samples 
produced by their respective native procedures (B and C). 
 
Table 9. Hydrodynamic diameter measured by DLS for the nanoparticles obtained by procedures A, 
A+A, B, B+B, C and C+C. 
Procedure Hydrodynamic diameter (nm) 
A 15.5 ± 1.9 
A+A 35.3 ± 5.0 
B 19.1 ± 7.2 
B+B 15.5 ± 1.1 130.0 ± 23.0 
C 18.7 ± 3.1 
C+C 25.7 ± 2.3 120.2 ± 26.4 
 
As can be observed in Table 9, and although XRD results did not give us that idea, 
DLS results indicate a significant change of the size of nanoparticles between samples 
prepared from procedures A and A+A. On the other hand, the results for the samples 
synthesized by procedures B+B and C+C indicate the formation of nanoparticles with 
two different hydrodynamic diameters that are not found in samples produced with B 
and C procedures. The existence of bimodal distributions for samples produced by 
procedures B+B and C+C can be possibly explained by the creation of more nucleation 
points with the Fe(acac)3 that was added and, as before, due to agglomeration.  
From the analysis of DLS results of Tables 7 and 9, we concluded that possibly, a 
reduction of the amount of oleylamine in the protective shell of the nanoparticles (B and 
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C procedures), in addiction with a procedure where time of growth of nanoparticles is 
increased, or where previously synthesized nanoparticles are added (as seeds) for the 
next synthesis, may promote an agglomeration of nanoparticles. Thus, it was decided to 
perform TEM analysis, in order to give us a reliable information about the particle size 
and agglomeration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
By observing Figure 27 and taking into account the confidence intervals, TEM 
results for particle sizes are consistent with those obtained from XRD analysis, meaning 
that each nanoparticle created from procedure A is composed by only one crystallite. 
Figure 27. TEM image and respective size distribution for sample of procedure A. 
50 nm 
Mean = 6.213 
σ = 1.235 
50 nm 
Figure 28. TEM image for sample of procedure A+A. 
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Thus, the DLS diameter seems to be oversized, which is possibly due to the 
hydrodynamic layer formed by the oleylamine coating (not clearly seen in TEM) and to 
some degree of agglomeration. 
The particle sizes of the sample produced by procedure A+A were impossible to 
quantify by TEM, due to the agglomeration of nanoparticles observable in the circled 
areas of Figure 28, where there is high uncertainty related with the beginning and end 
of the nanoparticles. Therefore, the DLS result, although it measures a different 
property, was also affected by this agglomerative effect.  
 
 
 
 
 
 
 
 
 
As can be noticed in Figure 29, procedure B allows the production of well-
dispersed iron oxide nanoparticles with average sizes consistent with the crystallite sizes 
obtained through XRD. Similar to procedure A, the nanoparticles prepared by procedure 
B are composed by a single crystallite but their size seems to be slightly lower. The DLS 
result for this sample was certainly also affected by the hydrophobic coating and some 
agglomeration. 
The samples prepared by procedure B+B were not tested by TEM, since we had 
other more promising samples to test, and the ones synthesized by A+A and C+C could 
serve as comparison for the extreme ratios of oleylamine/benzyl ether used. The next 
figures (Figures 30 and 31) show the obtained TEM results for the samples synthesized 
by procedures C and C+C.   
  
 
 
50 nm 
Mean = 5.345 
σ = 1.186 
Figure 29. TEM image and respective size distribution for sample of procedure B. 
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For samples prepared by procedure C, Figure 30 presents TEM results for particle 
sizes which continue to be consistent to those acquired from XRD analysis, if their 
confidence intervals are considered. Nanoparticles created by this procedure are also 
composed by a single crystallite and DLS results seem unreliable. It is important to refer 
the evident broader size distribution for this procedure in comparison with procedure A 
and B, given by the standard deviation values of 2.826, 1.235 and 1.186, respectively. 
50 nm 
Mean = 6.757 
σ = 2.826 
Figure 30. TEM image and respective size distribution for sample of procedure C. 
50 nm 
Figure 31. TEM image for sample of procedure C+C. 
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Once again, when we analyse the particle sizes of a sample produced by a 
procedure that uses previously prepared nanoparticles as points of nucleation for the 
next synthesis (C+C – Figure 31), it was impossible to quantify them by TEM. Apart from 
the observable formation of agglomerates of nanoparticles in the circled areas of Figure 
31, there are some outlined areas where it seems to appear a degree of organization 
between nanoparticles, like it a crystallization effect is occurring.  
Thus, the DLS measurements for samples of the C+C method are confirmed, due 
to the capacity of the instrument to separate and quantify the isolated nanoparticles 
from the agglomerates.  
We can conclude that for procedures A+A, B+B and C+C, during the synthesis of 
nanoparticles, not only the used seeds acted as points of nucleation for the next 
synthesis, being created more nucleation points with fresh Fe(acac)3 that the ones that 
were added. Therefore, few new nanoparticles were created similar to the first prepared 
ones, and others result from the growth and/or agglomeration of the prior 
nanoparticles. 
From the previous discussion, it is clear that the procedures that use the previously 
prepared nanoparticles as points of nucleation for the next synthesis – A+A, B+B and 
C+C - are not prone to obtain sized controlled iron oxide nanoparticles and, because of 
that, they were discarded and not considered the best routes to pursue this work.  
Procedure B was abandoned at this point, since the synthesis conditions are 
intermediate between A and C and TEM results proved that the nanoparticles produced 
by this procedure are the smallest ones. 
4.4. Impact of doubling the amount of Fe(acac)3 on the 
characteristics of the synthesized nanoparticles 
Also based on procedures A and C, procedures A(2x), and C(2x) were used with the 
objective of evaluating the influence of iron(III) acetylacetonate quantities in the SPIONs 
size, shape and magnetic characteristics. As it was described in the experimental 
procedures, the initial amount of Fe(acac)3 was doubled for these two procedures. 
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The samples synthesized by procedures A and A(2x) (Figure 32) depict a nearly 
perfect match between their respective diffractograms. Figure 33 also denotes a high 
similarity between the diffractograms obtained for the samples prepared by procedures 
C and C(2x), although different peak intensities. These XRD derived parameters are 
presented in the Table 10. 
 
 
Figure 32. Diffractograms for samples obtained by procedures A and A(2x). 
Figure 33. Diffractograms for samples obtained by procedures C and C(2x). 
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Table 10. XRD derived results for the lattice parameter and crystallites size of nanoparticles produced 
by procedures A, A(2x, C and C(2x). 
Procedure A A(2x) C C(2x) 
a (nm) 0.83540(11) 0.83815(21) 0.83613(34) 0.83884(24) 
D (nm) 6.85(81) 7.40(11) 6.36(20) 11.12(12) 
 
If we analyse the results in Table 10, it is noted an increase of the lattice parameter 
value for the samples synthesized by the procedures in which the amount of Fe(acac)3 
was doubled – A(2x) and C(2x), when compared with the corresponding native ones – A 
and C. Samples of procedures A(2x) and C(2x) are however still interpreted as mixtures 
of maghemite and magnetite, but this last phase seems to be the major contributing 
due to the higher proximity of the lattice parameter values of the samples and the 
reference value for magnetite (a=0.8396 nm). 
The same enhanced effect happens with the increase of the crystallite sizes of each 
set of samples, being more evident for sample prepared by procedure C(2x). 
 
 
The Mössbauer spectra, at 30 K, for the sample of procedure A (upper part of 
Figure 34) presents a broad line that clearly represents a superparamagnetic relaxation 
effect, not typical at this low temperature. Although maghemite is the main phase of 
Figure 34. Mössbauer spectra of the samples obtained by procedures A and A(2x), taken at 30 K. 
  
64 
 
this sample, magnetite also exists (in a lower amount). The spectrum was fitted with a 
sextet with an average hyperfine field of about 46.6(1) T, which is typical of maghemite 
with small particles size [54].  The hyperfine parameters obtained by the fitting of a set of 
Lorentzians to the data are shown in Table 11. 
 
Table 11. Mössbauer hyperfine parameters obtained by fitting the spectra shown in Figure 34,taken at 
30 K, for samples A (upper part) and A(2x) (lower part). 
Sub spectrum 
shape 
IS ± 0.01 
(mm/s)  
QS ± 0.001  
(mm/s) 
H ± 0.1 (T) 
FWHM ± 
0.1  (mm/s) 
Relative 
amount (%) 
Iron sites 
Sextet 0.51 -0.004 46.6 2.1 50.3 Fe3+ 
Singlet 0.53 --- --- 18.3 49.7 Fe3+ 
Sextet 1 0.54 -0.065 47.0 2.1 63.5 IV Fe3+ 
Sextet 2 0.45 0.075 50.0 2.6 36.5 VI Fe3+ 
 
In turn, the lower part of Figure 34 presents the Mössbauer spectra at 30 K for a 
sample of procedure A(2x) for which two sextets were fitted, with broad lines (≥ 2.0 
mm/s) and hyperfine fields of 47.0(1) T and 50.0(1) T that can be ascribed to magnetite 
with small particles (Figure 17) [54]. The characteristic line of magnetite at ~-3.5 mm/s is 
also present in this spectrum. Thus, comparing of the two spectra of Figure 34, the 
synthesis procedure A(2x), shows a higher content of magnetite, while the sample from 
procedure A has major amount of maghemite. These results are consistent with the 
earlier conclusions based on the obtained lattice parameter values from XRD analysis. 
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Table 12. Mössbauer hyperfine parameters obtained by fitting the spectra shown in Figure 35, taken 
at 30 K, for samples C (upper part) and C(2x) (lower part). 
  
The Mössbauer spectra shown in Figure 35, related to the samples produced by 
procedures C and C(2x), obviously indicates a mixture of magnetite and maghemite. The 
obtained spectra were fitted with the 5 magnetic sub-spectra model proposed by Berry 
Sub-spectrum 
shape 
IS ± 0.01 
(mm/s) 
QS ± 0.001  
(mm/s) 
H ± 0.1 
(T) 
FWHM ± 0.01  
(mm/s) 
Relative 
amount (%) 
Iron sites 
sextet 1 0.44 -0.120 44.0 0.90 5.5 Fe
2.5+ oct. 
sextet 2 1.13 -0.120 46.3 0.90 20.5 Fe
2+ oct. 
sextet 3 0.43 -0.260 49.7 0.90 21.2 Fe
2.5+ oct. 
sextet 4 0.48 0.240 50.3 0.90 18.7 Fe
3+ tet. 
sextet 5 0.42 -0.019 47.0 0.90 19.9 Fe
2.5+ oct. 
sextet 6 0.88 0.312 35.5 1.00 11.1 Fe
3+ 
doublet 0.60 0.700 ------- 0.70 3.1 Fe
3+ 
sextet  1 0.74 -1.038 44.0 0.60 6.3 Fe
2.5+ oct. 
sextet  2 0.96 0.137 45.3 0.60 15.7 Fe
2+ oct. 
sextet  3 0.43 0.024 49.0 0.55 29.1 Fe
2.5+ oct. 
sextet  4 0.37 -0.036 51.0 0.60 24.4 Fe
3+ tet. 
sextet  5 0.37 -0.020 46.4 0.55 17.5 Fe
2.5+ oct. 
sextet  6 0.48 0.036 37.8 0.65 7.0 Fe
3+ 
Figure 35. Mössbauer spectra of the samples obtained by procedures C and C(2x), taken at 30 K. 
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et al. with hyperfine fields between 51 T and 44 T, which is the common procedure used 
to fit magnetite spectra collected at low temperature [54]. From this fitting procedure, 
another sextet arised with a low field (Table 12 - 11% and 7% of the spectra for C and 
C(2x), respectively) that can be ascribed to maghemite with very small particles. For the 
sample prepared by procedure C, a Fe3+ doublet (3%) was also found in its spectrum, 
denoting a higher content of maghemite, when compared with the sample prepared 
with the doubled amount of Fe(acac)3 – C(2x). From these results, it is possible to state 
that samples obtained from procedures C and C(2x) have ~14% and 7% of maghemite, 
being the remaining part magnetite. This is a very high yield of magnetite. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TEM results for samples produced by procedures A(2x) and C(2x) are presented in 
Figures 36 and 37, respectively. In both samples the average size of particles increased 
Mean = 7.344 
σ = 2.660 
50 nm 
Figure 36. TEM image and respective size distribution for sample of procedure A(2x). 
Mean = 9.174 
σ = 2.974 
50 nm 
Figure 37. TEM image and respective size distribution for sample of procedure C(2x). 
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comparing to the TEM results obtained for samples synthesized by their native 
procedures, A and C (Figures 27 and 30) – 6.213 and 6.757 nm, respectively. This growth 
in particle size is consistent with the same increase in their respective crystallite sizes. 
Comparing these values we can assure that each particle is composed by a single 
crystallite, being these particles bigger when the amount of precursor is doubled during 
the synthesis of nanoparticles.   
 
Table 13. Hydrodynamic diameter measured by DLS for the nanoparticles obtained by procedures A, 
A(2x), C and C(2x). 
Procedure Hydrodynamic diameter (nm) 
A 15.5 ± 1.9 
A(2x) 24.8 ± 2.9 
C 18.7 ± 3.1 
C(2x) 28.6 ± 2.1 
 
As observed in Table 13, and as the XRD average crystallite size and TEM average 
particle size announced, the DLS results also indicate a significant increase in the size of 
nanoparticles between samples prepared from procedures A and A(2x). The same 
happened between samples prepared by procedures C and C(2x). 
These improved results for particles size leads us to believe that doubling the 
amount of Fe(acac)3 in the beginning of the synthesis is the most suitable route to 
pursue our goal. Thus, a further analysis of magnetic properties of the samples prepared 
by these procedures was done, always comparing them with the obtained results for the 
respective nanoparticles obtained by A and C procedures. 
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Figure 38 presents the thermograms showing the difference between the amounts 
of coating on nanoparticles for procedures A, A(2x), C and C(2x). This becomes clearer 
upon further analysis of the residual weight percentage of the samples, which indicate 
that  samples from procedure A have a 51.52% of coating to 48.48% of iron oxide, 
contrasting with the ratio obtained for samples of procedure A(2x) with 30.73% of 
coating to 69.27% of iron oxide. As for procedure C, a ratio of 37.31% of coating to 
62.69% of iron oxide was obtained, similar  with the ratio obtained for procedure  C(2x) 
of 39.45% to 60.55%. These results improved our understanding of the used procedures. 
When the amount of benzyl ether is lower, as in A and A(2x), the percentage of coating 
depends on the ratio between the volume of oleylamine and the amount of Fe(acac)3 
used during the synthesis. However, when the amount of benzyl ether is higher, as in C 
and C(2x), that dependence does not seems to exist since there is no significant 
difference in the percentage of coating. 
The calculated percentage of iron oxide for each procedure allows us to obtain the 
magnetic properties of the samples as function of their iron oxide masses instead of the 
total mass of each sample. In this way we have better means of comparison with 
theoretical magnetic values. 
In superparamagnetic materials, the magnetization M of these materials follows 
the Langevin’s law: 
𝑀 = 𝑛𝑚 [coth (
𝑚𝐻
𝑘𝑇
) −
𝑘𝑇
𝑚𝐻
]                                               (21) 
Figure 38. Thermograms of samples of procedures A (grey), A(2x) (red), C (green) and C(2x) (blue). 
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where, m is the magnetic moment of one particle which is, in first approximation, 
proportional to the volume of the particle, n is the number of particles, H is the magnetic 
field, k is the Boltzmann’s constant and T is the temperature. 
 The magnetization curves represent the behaviour of the magnetic moment 
(classified in emu: being 1 emu = 1000 A/m) as a function of the magnetic field and 
temperature. These curves will be now presented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. Magnetization as function of the applied field, for different temperatures - Sample A. 
Figure 40. Magnetization as function of the applied field, for different temperatures - Sample A(2x). 
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Figures 39 and 40 show the magnetization of the samples obtained by procedures 
A and A(2x), respectively. From their analysis, the magnetization saturation obtained, at 
300 K, for sample A (about 60 emu g-1) is higher than for sample A(2x), although until 20 
kOe the magnetization did not reach saturation. At lower temperatures, the 
magnetization saturation of both samples increased and, for sample A (73 emu g-1) the 
magnetization saturation continues to be higher than the obtained for the sample A(2x) 
- ~50 emu g-1. Is supposed that the inexistence of magnetization saturation may indicate 
presence of a paramagnetic effect probably due to the surfactant coating of oleylamine 
in the nanoparticles. 
According to literature, magnetization saturation values found for maghemite 
particles with 5 nm is 35 emu g-1at room temperature (RT) and 42 emu g-1at 5 K and, for 
magnetite particles of equal size, 50 emu g-1, at 5 K [57][58]. The values obtained in this 
work for samples A and A(2x) are higher than those obtained by Morales [57][58] for 
particle sizes of 5 nm, but the particle interactions are certainly different. 
For bulk maghemite and magnetite, in theory, magnetization saturations of 77 
emu/g and 82 emu/g at 5k are expected. The reduction of magnetization saturation in 
nanoparticles is a surface phenomenon. At the surface of magnetic materials, the spins 
are not as well oriented as observed in the interior, and this leads to a surface layer with 
very small magnetization saturation. As the surface/volume ratios of nanoparticles are 
larger by a few orders of magnitude than those of conventional materials, the 
contribution of spin disorder at the surface is important and causes a significant 
reduction in magnetization saturation [50]. 
 
 
 
 
 
 
 
 
 
Figure 41. Details of hysteresis curves shown in Figure 39. 
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Figure 41 and 42 show that the hysteresis curves are not reversible and that 
interparticle interaction exists. For all temperatures, except for T=2 K, the 
superparamagnetic properties are apparent, being these characterized by a vanishing 
hysteresis. At T=2 K, the magnetization curves clearly show hysteresis. For these 
samples, the blocking temperature is clearly in the range between 100 K and 2 K, as seen 
in the Figures. 
The coercive fields Hc are 392 Oe and 500 Oe for samples prepared by procedures 
A and A(2x), respectively. The remanent magnetization moment is about 30 emu/g for 
sample of procedure A and 18 emu/g for sample of procedure A(2x), also at 2K. 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. Details of hysteresis curves shown in Figure 40. 
Figure 43. Magnetization as function of the applied field, for different temperatures - Sample C. 
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In turn, for nanoparticles obtained from procedures C and C(2x), Figures 43 and 44 
show a different magnetization saturation phenomenon from the ones presented in 
figures 39 and 40. Here, the magnetization saturation revealed itself to be higher for the 
sample prepared by procedure C(2x) when compared with the one prepared by 
procedure C. For sample C, at 300 K, the magnetization does not saturate till 20 kOe 
(Figure 43), but it seems lower than the one obtained for sample C(2x) (68 emu g-1 – 
Figure 44). At lower temperatures, the magnetization saturation of both samples 
increases and, for sample C(2x) (78 emu g-1) the magnetization saturation continues to 
be higher than the “apparent” one of sample C. These obtained values for samples C 
and C(2x) continue to be slightly higher than those obtained by Morales [57][58], but as 
referred, our results are influenced by particle interactions. 
 
 
 
 
 
 
 
 
 
 
Figure 44. Magnetization as function of the applied field, for different temperatures - Sample C(2x). 
Figure 45. Details of hysteresis curves shown in Figure 43. 
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Figures 45 and 46 show that the hysteresis curves are also not reversible and that 
interparticle interaction exists for the samples produced by these two procedures. As in 
samples from procedures A and A(2x), with exception of T=2 K, for all the tested 
temperatures, the superparamagnetic properties of samples C and C(2x) are apparent, 
being these characterized by a vanishing hysteresis, while at T=2 K the magnetization 
curves clearly show hysteresis. The coercive fields for procedures C and C(2x) are 440 
Oe and 320 Oe, respectively. The remanent magnetization moment is about 26 emu g-1 
for procedure C, and 25 emu g-1 for procedure C(2x). 
 
 
Figure 46. Details of hysteresis curves shown in Figure 44. 
Figure 47. FC and ZFC curves of samples obtained from procedures A and A(2x), at H=100 Oe. 
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Field cooled (FC) and zero-field cooled (ZFC) magnetization curves of samples A 
and A(2x) were measured at 100 Oe as function of temperature, from 2 K to 300 K (Figure 
47). From the analysis of these curves, we were able to calculate the blocking 
temperature for these samples, about 40.1 K and 102.3 K for procedures A and A(2x), 
respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
The same analysis was done from FC and ZFC curves of samples of procedures C 
and C(2x), measured in equal conditions to the ones of procedures A and A(2x). The 
blocking temperature is about 110.7 K and 116.0 K for samples by procedures C and 
C(2x), respectively. 
ZFC curves shown in Figures 47 and 48 show negative remanent magnetization 
(NRM), which increase at lower applied fields (e.g. -4.12 and -5.60 emu g-1 were 
registered for sample C, at 50 and 100 Oe, respectively). The existence of NRM in 
homogeneous magnetic materials is still in debate, but recently a physical justification 
was given for homogeneous nanoparticles [59]. This justification applies a “wasp-waist” 
model in combination with energy calculations.  
The temperature dependence shown for FC magnetization of samples A(2x) and 
C(2x) is weaker than that of the one observed from FC curves of A and C samples, 
indicating higher particle interaction in the samples produced by procedures where the 
amount of Fe(acac)3 was doubled.   
Figure 48. FC and ZFC curves of samples obtained from procedures C and C(2x), at H=100 Oe. 
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Considering Langvin’s law (eq. 21), the magnetic moment of superparamagnetic 
materials can be seen as a temperature independent function of H/T ratio. Therefore, 
plotting magnetization curves, at different temperatures over H/T ratio, provides a clear 
indication regarding the validity of Langvin’s function, thus confirms the existence of 
superparamagnetism. That analysis is shown in Figures 49, 50, 51 and 52.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49. Magnetization, at different temperatures, as function of H/T ratios - Sample A. 
Figure 50. Magnetization, at different temperatures, as function of H/T ratios - Sample A(2x). 
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Figures 49, 50, 51 and 52 prove Langvin’s law and, consequently, the existence of 
superparamagnetic behaviour for all of the tested samples and temperatures, with 
exception for T=2 K, where the magnetic moment of the samples cannot be regarded as 
temperature independent in relation to the H/T ratio. From the analysis of Figure 49, for 
T=20 K, it is visible a loss of superparamagnetic behaviour by the particles, attributed to 
the deviance from the curves for other temperatures. 
After measuring different size properties of the produced nanoparticles as well as 
their magnetic, phase and shape properties, a better understanding of the chemical 
structure of the coating is needed. That knowledge was obtained by performing a FTIR 
Figure 51. Magnetization, at different temperatures, as function of H/T ratios - Sample C. 
Figure 52. Magnetization, at different temperatures, as function of H/T ratios - Sample C(2x). 
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analysis on the synthesized samples of the procedures A, A(2x), C and C(2x). The 
obtained spectra are shown in Figure 53. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tran
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Figure 53. FTIR spectra obtained for the samples of procedures A, A(2x), C and C(2x), respectively. 
A 
A(2x) 
C 
C(2x) 
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Even though the four procedures of the synthesis of nanoparticles used the same 
reactants, the coating of nanoparticles might be affected by the different amount of 
each (Figure 53). The spectra baseline hardly recovers back after achieving a peak due 
to the broad bands characteristic of amine groups (being difficult the identification of 
other chemical bonds in that wavenumber band), which strongly confirms the 
oleylamine presence in the samples. The spectra of the samples from the procedures C 
and C(2x) differs from the spectra acquired for samples A and A(2x), due to the 
overwhelming presence of benzyl ether (3100-3000 cm-1, 2000-1800 cm-1, 1300-1020 
cm-1 and the peaks displayed in Figure 53 as C=C aromatic), which dominates great part 
of the spectra. All the characteristic vibrations from this compound often create peaks 
of higher intensity or slight deviations from where those peaks were expected to be.   
Despite the presence of the spectra peaks related to the N-H bonds (typical of 
oleylamine) in all samples, the spectra of samples from procedures A and A(2x) display 
fewer and smoother peaks, related to the benzyl ether bonds, barely suggesting the 
presence of this compound, contrary to what is seen in samples C and C(2x). This fact 
confirms what was expected, since these last samples used a smaller amount of benzyl 
ether and a higher of oleylamine during their synthesis. It allows to conclude as well that 
the coating in procedures A and A(2x) is rather simple and only being composed of 
oleylamine. However, samples form procedure C and C(2x) have a more complex 
coating. Its IR spectra suggests an interaction between oleylamine and benzyl ether to 
form the coating of the nanoparticles. Therefore, these specific amounts of reactants 
seem to favour the anchoring of the benzyl ether molecules in the coating. 
The spectrum of magnetite has broads at 580 and 400 cm-1, while the spectrum of 
maghemite shows broad bands at 700, 640-660, 620, 580, 560, 460 and 430 cm-1.  In 
spite of the Fe-O bond at 580 cm-1 is shown in all obtained spectra, which strongly 
confirms the presence of magnetite and/or maghemite, the distinction between 
maghemite and magnetite is difficult to evaluate due to the slight deviation of the peaks, 
when comparing with the reference. Despite this fact, all spectra suggest the existence 
of maghemite in the produced nanoparticles.   
By this point, size, shape, phase and magnetic properties, as well as the chemical 
structure of coating of the produced iron oxide nanoparticles were assessed. They 
revealed us that, although they have a larger size distribution, a lower coercive field and 
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more particle interactions, samples prepared by procedure C(2x) are mainly composed 
by magnetite (Mössbauer and XRD results) and have the highest increase in size (XRD, 
DLS and TEM results), highest magnetization saturation (VSM results), with a  oleylamine 
and benzyl ether coating. Therefore, procedure C(2x) was the one chosen to continue 
the further studies of dispersion stability, cytotoxicity and proteins adsorption analysis, 
since it revealed itself the most promising one to synthesize high quality, size controlled 
superparamagnetic iron oxide nanoparticles (SPIONS). This analysis will also be done to 
samples of procedure C just to provide a comparison basis. 
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5. Discussion of results for SPIONs application – Biological Aspects 
In this chapter we will describe and discuss the results of the influence of 
surfactant on SPION stability in water dispersions, the SPION cytotoxicity, as well as the 
protein adsorption efficacy using SPIONs as the adsorbent matrix.  
5.1. Influence of surfactant on superparamagnetic iron oxide 
nanoparticle stability in water dispersions 
Owing to chemical nature of the SPIONs, a stable aqueous suspension is not 
possible to obtain with further development. On the other hand, a water-based SPION 
suspension is preferred in order to evaluate both, in vitro and in vivo biological SPION 
properties. With the aim to obtain aqueous stable suspensions, two different 
compounds with surfactant properties were tested: bovine serum albumin (BSA) and 
polysorbate 80 (Tween 80).  As it was described in section 3.3., several concentrations 
of the surfactant compounds were previous dissolved in phosphate buffer saline (PBS) 
solution (from 1% to 3% for BSA and1% to 5% for Tween 80) , being these mixtures used 
as the SPION’s re-dispersion solvents. The aim was to determine which surfactant 
solution and whose concentration permits longer and more physical stability of the 
Fe3O4 nanoparticles suspension.  
With this intention, the stored solutions of Fe3O4 nanoparticles were dried in 
cuvettes and the different surfactant mixtures were added. An ultrasonic bath was 
applied to homogenize those suspensions. After 8 h rest period, the transmittance of 
the suspensions was directly measured in the UV-Vis spectrometer. Additionally, two 
controls were made without surfactant, being only composed by nanoparticles in PBS. 
One of them was also subjected to the rest period (Control 1) and, the other was 
thoroughly mixed before measuring its transmittance (Control 2). 
The transmittance value of the Control 1 represents normal stability (without 
surfactant) of the nanoparticles in PBS, after the rest period, while the transmittance of 
the Control 2 corresponds to the potential maximum value of the stability of the 
nanoparticles in suspension. Therefore, the higher values of the transmittances of the 
samples measured were matched to poor results of stability of the nanoparticles in 
suspensions.  
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The results of UV-VIS spectroscopy were obtained after an 8 h period of rest of the 
SPIONs re-dispersions, displayed in the Figure 54.a) and 54.b). By the analysis of Figures 
54.a) and 54.b), a wavelength of 500 nm can easily distinguish the obtained results, 
before reaches the transmittance threshold. Figure 54.C shows the obtained average 
results and respective standard deviation for all re-dispersion solvents used at a 
wavelength of 500 nm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
% Transmittance 
(500nm) Mean 
Standard 
Deviation 
Control 1 94.5 0.1 
Control 2 2.00 0.1 
Tween80 
5% 37.1 0.4 
4% 31.9 0.1 
3% 32.4 0.1 
2% 26.2 0.1 
1% 24.5 1.2 
BSA 
3% 58.8 0.2 
2% 57.9 0.2 
1% 57.0 0.2 
a) 
b) 
c) 
Figure 54. UV-Vis results for samples obtained by procedure C(2x) re-dispersed in PBS and mixtures of 
BSA (a)) and Tween 80 (b)) in PBS in different concentrations. The transmittance results of all samples 
for a wavelength of 500 nm are also presented(c)). 
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The analysis of Figure 54.a) demonstrates that the presence of BSA in PBS solutions 
decreases the percentage of transmittance when compared with the PBS solution alone. 
This ultimately indicates that in fact BSA increases the stability of SPIONs in cell 
solutions. Of note, the insignificant influence of BSA concentration in the percentage of 
transmittance – showed in Figure 54.c) - and, consequently, in the stability of 
dispersions. 
The presence of Tween 80 in PBS solutions also reduces the percentage of 
transmittance from the PBS solution standalone, improving the stability of SPIONs. 
Moreover, by analysing Figure 54.b) and c), it seems that a minor concentration of 
Tween 80 is beneficial for that stabilization to occur. If we now compare the two 
surfactants, Tween 80 presents higher capacity to improve the stabilization of the 
prepared nanoparticles in water and cell solutions, due to the lower percentage of 
transmittance registered. 
Thus, during the planning of the procedures for the remaining SPIONs 
characterization that concept was taken into account and small amounts of Tween 80 
were used to improve the results of these analysis. 
5.2. Evaluation of the iron oxide nanoparticle cytotoxicity 
Testing the effect of compounds on the viability of cell grown in culture is widely 
used as a predictor of potential toxic effects in whole animals. The MTT assays is a 
colorimetric assay and allows the determination of the cell viability through the direct 
measurement of the cell enzymatic metabolic activity. In order to perform cytotoxic 
tests of the synthesized nanoparticles, an improvement of the protocol was necessary.  
With this intuit, different concentrations of nanoparticles dispersed in medium of 
culture (DMEM) - from 0.975 to 2000 µg/ml, were added to cos-7 adherent cells, already 
seeded in a 96-well plate in DMEM. After a day of incubation, the MTT in PBS (pH=7.4) 
was added to each well and incubated for more 2 h at 37 °C. Then, the medium was 
removed and formazan crystals produced by metabolic active cells were solubilized with 
the addition of DMSO in each well. Then, a centrifugation was performed to precipitate 
the nanoparticles and the optical density (OD) of the supernatant was measured at 540 
nm with 630 nm as wavelength reference. The measurement of the optical density (OD) 
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allowed the determination of the cell viability (%) (see eq. 18) for each concentration of 
nanoparticles.  
Figures 55 illustrates the cytotoxic effect of the prepared SPIONs through a 
representation of the percentage of cell viability as function of the logarithm of the 
several concentrations – in µg/ml – of nanoparticles that were in contact with cos-7 cells. 
These figures also show the best fitting to the curve of results, as well as the IC50 (the 
concentration needed for 50% of the cells to die) for nanoparticles obtained by 
procedures C and C(2x). 
The IC50 was calculated by solving the polynomial equation of the curve that best 
fits the results (see Table 14.). By solving the 6th degree polynomial equations, the 
calculated IC50 is 303.92 µg/ml for samples of procedure C and 759.07 µg/ml for samples 
of procedure C(2x). These particular results show a less cytotoxic effect for samples 
originated by procedure C(2x).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14. Parameters of the curve that fits the results for samples produced by both procedures 
(equation, R2 and the result of IC50). 
Sample Polynomial Equation R2 IC50 (µg/ml) 
C 
y = -2.4218x6 + 30.88x5 – 132.15x4 + 228.61x3 – 
149.4x2 + 19.646x + 98.825 
0.9999 
303.92 
C(2x) 
y = 8.856x6 – 81.669x5 + 280.11x4 – 449.9x3 + 
341x2 – 94.678x + 98.754 
759.07 
IC50 – 759.07 µg/ml 
IC50 – 303.92 µg/ml 
Figure 55. Viability of cos-7 cells as function of the logarithm of the concentration of nanoparticles 
prepared by procedures C (red) and C(2x) (blue). 
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5.3. Evaluation of BSA and α-casein adsorption efficacy 
Since the main focus of this work is to apply this system for located drug-delivery, 
the measurement of the surface charge of the prepared nanoparticles was needed to 
understand to which protein we could apply the adsorption procedure and how strong 
would be the interaction between protein and nanoparticles. 
Therefore, the Fe3O4 nanoparticles dispersed in PBS (6.66 mg/ml) were re-
dispersed in several biocompatible solutions with different pH (water, PBS and acetate 
buffer with pH=5 and pH=3.6) using a dilution factor of 10 (100 µl:1 ml). The Zeta 
potential of these re-dispersions was determined and the average values are displayed 
in Table 15.   
Table 15. Zeta Potential results for nanoparticles re-dispersed in solutions with different pH. 
 
Thus, water and acetate buffer with a pH=5.0 were the re-dispersive solutions 
selected to employ during the protein adsorption tests. Although the surface charge of 
the produced nanoparticles is not as high as in the other acetate buffer, and because 
the interactions between nanoparticles and the proteins could be weak, their pH does 
not varies from the physiological pH of brain as when acetate buffer with pH=3.6 was 
used.  
Bovine serum albumin (BSA) and α-casein were chosen as the proteins for 
adsorption tests, since they have isoelectric points (4.7 and 4.2-4.7, respectively) similar 
to the pH of the buffers selected. For brain therapeutic purposes, these proteins have 
no particular applications; however, they served as model of therapeutic proteins. The 
two used properties – loading efficiency and capacity (see eq. 19 and 20), evaluate the 
efficiency of bonding between the protein and the nanoparticles (relates the mass of 
protein attached to nanoparticles and to the initial mass of protein used) and the 
Type of suspension 
𝒁𝒆𝒕𝒂 𝑷𝒐𝒕𝒆𝒏𝒕𝒊𝒂𝒍 ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  
(mV) 
𝝈(𝒁𝒆𝒕𝒂 𝑷𝒐𝒕𝒆𝒏𝒕𝒊𝒂𝒍 ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ) 
(mV) 
Water : Nanoparticles in PBS (1ml:100µl) 7.776 0.527 
PBS : Nanoparticles in PBS (1ml:100µl) -3.148 0.326 
Acetate Buffer (pH=3,6) : Nanoparticles in PBS (1ml:100µl) 14.282 1.982 
Acetate Buffer (pH=5,0) : Nanoparticles in PBS (1ml:100µl) 8.140 0.962 
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capacity of nanoparticles to attach protein to their surface (relates the mass of protein 
bond to the nanoparticles and the mass of nanoparticles employed), respectively. 
  With this aim, nanoparticles were suspended (1 mg/ml) in water or acetate buffer 
and they were mixed in same extents with protein solutions comprising several 
concentrations from 25 to 700 µg/ml for 0.5 h. Subsequently, a centrifugation process 
was applied in order to remove the supernatant. Finally, the non-adsorbed protein was 
quantified by implementing a colorimetric procedure - Lowry protocol (see section 
3.5.11.).  
The results of measuring the proteins loading efficiency and the loading capacity 
of the nanoparticles prepared from procedures C and C(2x), as function of the initial 
concentration of BSA mixed with nanoparticles is shown in Figures 56 and 57, 
respectively. 
 
 
The analysis of Figure 56 revealed a higher loading efficiency (%) for lower 
concentrations of BSA. Moreover, BSA has greater loading efficiency with nanoparticles 
prepared by procedure C(2x) when 50 ≤ [BSA] ≤ 150 µg/ml with water used as the 
solution where both samples of nanoparticle were suspended. Regardless of the 
concentration of BSA, when acetate buffer was employed the loading efficiency of BSA 
was significantly higher for samples of nanoparticles produced from procedure C(2x). 
Figure 56. Obtained loading efficiency (%) as function of the concentration of BSA (µg/ml) using Water (left) 
and Acetate buffer of pH=5.0 (right) as the SPIONs re-dispersive solutions. 
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As for loading efficiency, nanoparticles of procedure C(2x) have greater loading 
capacity (Figure 57)  when 50 ≤ [BSA] ≤ 150 µg/ml with water used as the solution where 
both samples of nanoparticles were suspended. The observed peak for 100 µg/ml of BSA 
for nanoparticles prepared by procedure C(2x) re-dispersed in water could be related to 
an increase in interactions between BSA molecules attached to the SPIONs and free BSA 
molecules of each solution or can be related to the possibility of having distinct amount 
of nanoparticles with different sizes  in each sample. When acetate buffer was used, the 
loading capacity of nanoparticles of procedure C shows constantly lower that the one 
produced by procedure C(2x), regardless of the BSA concentration. These results 
demonstrate that the nanoparticles synthesized from procedure C(2x) are the most 
suitable to adsorb BSA and to potentially be used as nano-carriers for drug delivery 
systems to be applied for brain therapeutic purposes. 
The assessment about the type of the used re-dispersant solutions can be 
obtained when a single type of nanoparticles is highlighted. The results for loading 
efficiency and capacity related to the concentration of BSA for nanoparticles by 
procedure C(2x) are displayed in Figure 58. 
 
 
Figure 57. Obtained loading capacity (%) as function of the concentration of BSA (µg/ml) using Water 
(left) and Acetate buffer of pH=5.0 (right) as the SPIONs re-dispersive solutions. 
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According to Figure 58, there is a dependence relation between the loading 
efficiency/capacity and the two used re-dispersant solutions. As a result, for low 
concentrations of BSA (25 ≤ [BSA] ≤ 125 µg/ml), both calculated loading efficiency and 
loading capacity are higher when water is used but, beyond concentrations of 125 µg/ml 
of BSA, these adsorption properties are enhanced when acetate buffer (pH=5) was 
employed. 
When the same method was used to evaluate the properties of α-casein 
adsorption, the protein did not dissolve in both of the re-dispersant solutions employed. 
Therefore, when the centrifugation process was performed, almost all of the protein 
precipitated, giving us variable and inaccurate results about the amount of protein 
adsorbed by the prepared Fe3O4 nanoparticles. From this analysis is possible to conclude 
that, when selecting a biocompatible re-dispersant solution, it must completely dissolve 
the protein of interest.  
For brain treatment purposes another protein should be chosen but, its adsorption 
profile may not be the same and the solution where nanoparticles are suspended must 
be also carefully selected. Nevertheless, it became proved that the protein adsorption 
by the prepared nanoparticles can be enhanced with a proper selection between the re-
dispersant solution and the drug/protein concentration. 
Figure 58. Obtained loading efficiency (left) and capacity (right) as function of the concentration 
of BSA (µg/ml) for nanoparticles of procedure C(2x). 
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6. Conclusions and Future Work 
In the present work, we studied several aspects on how to achieve the best 
possible biodegradable magnetic system for targeted drug delivery in the brain. In order 
to this, we followed the procedure described by Xu et al. [45], where oleylamine acted as 
both a reducing agent and a stabilizer to produce SPIONs – procedure A.   
To better understand the influence of oleylamine and benzyl ether in the synthesis 
reaction and in the characteristics of nanoparticles, procedures B and C were designed 
by changing the ratio between the amounts of these two reactants.  
Since the initial aim was to increase the average size of nanoparticles produced by 
Xu to assure their passage through the blood-brain barrier, three more synthesis 
procedures were additionally defined by extending the time of the nanocrystals growth 
by one hour (procedures A*, B* and C*). The samples from these procedures were 
characterized through XRD and DLS and the results compared with those obtained for 
their native procedures (A, B and C). 
 XRD and DLS results for the samples of procedures A*, B* and C* didn’t reveal the 
desired increase of nanoparticles size and amount of magnetite. Besides that, we have 
concluded that increasing the time of growth of nanocrystals may have an 
agglomerative effect during its synthesis. The agglomeration of nanoparticles enhances 
their toxic effect and, theoretically, reduces the drug absorption as the area/volume 
ratio is decreased.   
Next, and using procedures A, B and C methods as basis, we developed a 
procedure where the previously prepared nanoparticles were used as seeds or points of 
nucleation for the next nanoparticles synthesis, hoping that the new iron(III) 
acetylacetonate was only used in the nanocrystals growth– procedures A+A, B+B and 
C+C.  
The XRD results showed a general increase of the amount of magnetite and of the 
average crystallite size but, from DLS and TEM results, we concluded that not all of the 
previous used nanoparticles acted as points of nucleation for the next synthesis, being 
created more nucleation points with the added Fe(acac)3. Thus, few new nanoparticles 
were created, similar to the first ones and other particles grew or suffered 
agglomeration. 
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At this point, procedure B and all resulting from this one were discarded due their 
intermedium conditions of reactants, which always led to results in between the other 
two procedures.  
After, we focused on the study of the influence of doubling the amount of 
precursor, iron(III) acetylacetonate, taking the basis of procedures A and C. Since XRD 
lattice parameter, TEM and DLS results were consistent and showed a significant growth 
of nanoparticles, and, additionally, Mössbauer and XRD results proved to have an 
increase of the amount of magnetite between the samples in which the precursor was 
doubled – A(2x) and C(2x) –when compared to the samples produced by their native 
procedures,  a further magnetic and coating characterization was applied. 
VSM results presented a higher magnetization saturation for procedure A when 
comparing with procedure A(2x). However, the opposite was found for C and C(2x), 
where C(2x) had higher magnetization saturation than C. They also showed the highest 
coercive field for sample A(2x) and the lowest for C(2x), being the remanent 
magnetization approximately similar for samples of both procedures.  
Although non-reversibility was found in the hysteresis curve in the VSM, as well as 
higher values of magnetization saturation when comparing to the references for 
maghemite and magnetite (which indicates the existence of particle interactions), TEM 
results revealed well dispersed nanoparticles. 
FTIR analysis lead us to conclude that the coating in samples from procedures A, 
A(2x) and C(2x) is rather simple and only being composed of oleylamine. However, 
procedure C has a more complex coating. Its IR spectra suggests an interaction between 
oleylamine and benzyl ether to form the coating of nanoparticles. 
Thus, and although samples of procedure C(2x) had a larger size distribution, a 
lower coercive field and more particle interactions, they were mainly composed of 
magnetite (Mössbauer and XRD results) and had the highest increase in size (XRD, DLS 
and TEM results), highest magnetization saturation (VSM results), with a simple 
oleylamine coating, making this the elected procedure to pursuit our work. 
One of the purposes of this work was to stabilize the SPIONs in water allowing 
them to be applied in future human brain cells treatment. Therefore, Tween 80 and BSA 
were tested as surfactants, mixing them in different concentrations with a PBS solution, 
and being these mixtures used as the SPION’s re-dispersion solvents. 
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UV-Vis results revealed that both surfactants improved the stability of SPIONs. 
Moreover, the highest capacity to increase the stabilization of the prepared 
nanoparticles in water and cell culture medium was found for small concentrations of 
Tween 80. Thus, this concept was taken into account and small amounts of Tween 80 
were used to improve the results of cytotoxicity and proteins’ adsorption analysis.  
Cytotoxicity tests performed on the nanoparticles synthesized by procedures C 
and C(2x) revealed an IC50 of 303.917 µg/ml  and 759.071 µg/ml, respectively,  with cos-
7 cells. The results elucidate us about the lower toxic effect of nanoparticles produced 
from procedure C(2x). 
Finally, the surface charge of the prepared nanoparticles dispersed in different 
solutions was evaluated and it showed that water and acetate buffer with a pH=5.0 were 
suitable solutions, capable to enhance the surface charge of the nanoparticles. Although 
their surface charge is not as high as in the acetate buffer with pH=3.6, and because of 
the interactions between the proteins and nanoparticles could be weaker, the pH=5 is 
more close to the physiological pH of brain, potentially allowing a normal function and 
behaviour of this organ.  
Despite they have no declared effect in brain treatments, BSA and α-casein were 
chosen as the model proteins for testing adsorption on the nanoparticles, since they 
have an isoelectric point similar to the pH of the buffers selected. After promoting the 
protein adsorption, the obtained results from the application of Lowry protocol, for 
quantification of protein, indicated higher values of loading efficiency of BSA and loading 
capacity of nanoparticles for smaller concentrations of BSA (50 ≤ [BSA] ≤ 150 µg/ml) 
when water was used as an re-dispersant solution.  When acetate buffer was employed, 
the loading efficiency of BSA and the loading capacity of nanoparticles from procedure 
C were always lower than for the nanoparticles produced by procedure C(2x), regardless 
of the BSA concentration. 
Regarding the of the solution used, the results showed that for low concentrations 
of BSA (25 ≤ [BSA] ≤ 125 µg/ml) both calculated loading efficiency and loading capacity 
are higher when water was used but, beyond concentrations of 125 µg/ml of BSA, these 
adsorption properties are enhanced with acetate buffer (pH=5). 
When the same method was employed to evaluate the properties of α-casein 
adsorption, the protein did not dissolve in both of the re-dispersant solutions. 
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Therefore, it gave us variable and inaccurate results of the amount of protein adsorbed 
by the prepared Fe3O4 nanoparticles. From this analysis, it was possible to conclude that, 
when selecting a biocompatible re-dispersant solution to enhance the surface charge of 
nanoparticles, it must completely dissolve the protein of interest.  
Concluding, it is of our understanding that a biodegradable magnetic nano-carrier 
for drug delivery in brain can be assembled by using a therapeutic protein and the iron 
oxide nanoparticles synthesized in this work. The relatively narrow size distribution, the 
low toxicity of the nanoparticles and a proper selection of the re-dispersant solution and 
protein concentration can constitute a novel route to develop therapeutic treatment in 
brain. 
There are still some questions that were brought up during the course of this work 
and can be vectors for future work. One possible effort is to improve the study made by 
VSM and Mössbauer, by using iron oxide nanoparticles with the stabilizing coating – 
Tween 80 – and with the protein adsorbed. This would give us a better insight into the 
magnetic properties of the overall drug delivery system instead of the nanoparticles by 
themselves. 
Another possible exertion is to improve the study about the protein adsorption by 
using a known brain’s therapeutic protein and a re-dispersant solution that takes into 
account the proteins characteristics and brain’s physiological conditions. 
The forces related to the protein adsorption on the produced SPIONs could also 
be evaluated by resorting to Atomic Force Microscopy (AFM) tests. 
At last, a complete in vivo test could be done to determine the drug releasing 
kinetics and, consequently, evaluating the efficiency of this developed technology.  
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